Document and Entity Information
Document and Entity Information - shares | 9 Months Ended | |
Sep. 30, 2022 | Nov. 01, 2022 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Amendment Flag | false | |
Document Period End Date | Sep. 30, 2022 | |
Document Fiscal Year Focus | 2022 | |
Document Fiscal Period Focus | Q3 | |
Trading Symbol | CMBM | |
Entity Registrant Name | CAMBIUM NETWORKS CORP | |
Entity Central Index Key | 0001738177 | |
Current Fiscal Year End Date | --12-31 | |
Entity Filer Category | Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | true | |
Entity Ex Transition Period | true | |
Entity Interactive Data Current | Yes | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 27,035,371 | |
Entity Current Reporting Status | Yes | |
Entity File Number | 001-38952 | |
Entity Tax Identification Number | 00-0000000 | |
Entity Address, Address Line One | 3800 Golf Road | |
Entity Address, Address Line Two | Suite 360 | |
Entity Address, City or Town | Rolling Meadows | |
Entity Address, State or Province | IL | |
Entity Address, Postal Zip Code | 60008 | |
City Area Code | 345 | |
Local Phone Number | 943-3100 | |
Entity Incorporation State Country Code | E9 | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Title of 12(b) Security | Ordinary shares, $0.0001 par value | |
Security Exchange Name | NASDAQ |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Sep. 30, 2022 | Dec. 31, 2021 |
Current assets | ||
Cash | $ 44,859 | $ 59,291 |
Receivables, net of allowances of $683 and $634 | 84,352 | 69,773 |
Inventories, net | 50,641 | 33,777 |
Recoverable income taxes | 299 | 860 |
Prepaid expenses | 8,088 | 12,170 |
Other current assets | 5,816 | 4,718 |
Total current assets | 194,055 | 180,589 |
Noncurrent assets | ||
Property and equipment, net | 11,054 | 10,490 |
Software, net | 7,772 | 5,867 |
Operating lease assets | 4,548 | 5,899 |
Intangible assets, net | 9,548 | 10,777 |
Goodwill | 9,842 | 9,842 |
Deferred tax assets, net | 9,593 | 7,604 |
Other noncurrent assets | 1,035 | 1,200 |
TOTAL ASSETS | 247,447 | 232,268 |
Current liabilities | ||
Accounts payable | 28,167 | 28,241 |
Accrued liabilities | 27,312 | 21,948 |
Employee compensation | 6,475 | 16,601 |
Current portion of long-term external debt, net | 3,155 | 2,489 |
Deferred revenues | 8,226 | 6,880 |
Other current liabilities | 6,853 | 5,981 |
Total current liabilities | 80,188 | 82,140 |
Noncurrent liabilities | ||
Long-term external debt, net | 25,090 | 26,965 |
Deferred revenues | 8,201 | 5,363 |
Noncurrent operating lease liabilities | 2,558 | 4,112 |
Other noncurrent liabilities | 1,589 | 1,551 |
Total liabilities | 117,626 | 120,131 |
Shareholders' equity | ||
Share capital; $0.0001 par value; 500,000,000 shares authorized at December 31, 2021 and September 30, 2022; 26,892,082 shares issued and 26,735,175 outstanding at December 31, 2021 and 27,216,120 shares issued and 27,016,104 outstanding at September 30, 2022 | 3 | 3 |
Additional paid in capital | 133,158 | 124,117 |
Treasury shares, at cost, 156,907 shares at December 31, 2021 and 200,016 shares at September 30, 2022 | (4,723) | (3,906) |
Accumulated deficit | 2,811 | (7,378) |
Accumulated other comprehensive loss | (1,428) | (699) |
Total shareholders' equity | 129,821 | 112,137 |
TOTAL LIABILITIES AND EQUITY | $ 247,447 | $ 232,268 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands | Sep. 30, 2022 | Dec. 31, 2021 |
Statement of Financial Position [Abstract] | ||
Allowances for receivables | $ 634 | $ 683 |
Common stock, par value | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized | 500,000,000 | 500,000,000 |
Common stock, shares issued | 27,216,120 | 26,892,082 |
Common stock, shares, outstanding | 27,016,104 | 26,735,175 |
Treasury stock, shares | 200,016 | 156,907 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Operations - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Income Statement [Abstract] | ||||
Revenues | $ 81,200 | $ 75,920 | $ 212,392 | $ 257,144 |
Cost of revenues | 40,034 | 39,900 | 108,621 | 130,862 |
Gross profit | 41,166 | 36,020 | 103,771 | 126,282 |
Operating expenses | ||||
Research and development | 11,747 | 12,082 | 34,425 | 36,302 |
Sales and marketing | 10,767 | 9,938 | 31,494 | 29,696 |
General and administrative | 7,186 | 6,640 | 22,936 | 22,065 |
Depreciation and amortization | 1,506 | 1,548 | 4,486 | 4,707 |
Total operating expenses | 31,206 | 30,208 | 93,341 | 92,770 |
Operating income | 9,960 | 5,812 | 10,430 | 33,512 |
Interest expense, net | 514 | 752 | 1,418 | 3,208 |
Other expense (income), net | 165 | 88 | (129) | 209 |
Income before income taxes | 9,281 | 4,972 | 9,141 | 30,095 |
Provision (benefit) for income taxes | (154) | 355 | (1,048) | (5,899) |
Net income | $ 9,435 | $ 4,617 | $ 10,189 | $ 35,994 |
Earnings per share | ||||
Basic | $ 0.35 | $ 0.17 | $ 0.38 | $ 1.37 |
Diluted | $ 0.34 | $ 0.16 | $ 0.36 | $ 1.25 |
Weighted-average number of shares outstanding to compute net earnings per share | ||||
Basic | 26,977,155 | 26,540,843 | 26,855,395 | 26,342,113 |
Diluted | 27,979,575 | 28,639,177 | 27,939,728 | 28,705,677 |
Condensed Consolidated Statem_2
Condensed Consolidated Statements of Operations (Parenthetical) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Share-based compensation included in costs and expenses | $ 2,848 | $ 2,076 | $ 7,785 | $ 5,584 |
Cost of Revenues | ||||
Share-based compensation included in costs and expenses | 56 | 39 | 163 | 108 |
Research and Development | ||||
Share-based compensation included in costs and expenses | 1,241 | 834 | 3,274 | 2,193 |
Sales and Marketing | ||||
Share-based compensation included in costs and expenses | 696 | 540 | 1,901 | 1,374 |
General and Administrative | ||||
Share-based compensation included in costs and expenses | $ 855 | $ 663 | $ 2,447 | $ 1,909 |
Condensed Consolidated Statem_3
Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Statement of Comprehensive Income [Abstract] | ||||
Net Income | $ 9,435 | $ 4,617 | $ 10,189 | $ 35,994 |
Other comprehensive loss | ||||
Foreign currency translation adjustment | (283) | (38) | (729) | (122) |
Comprehensive income | $ 9,152 | $ 4,579 | $ 9,460 | $ 35,872 |
Condensed Consolidated Statem_4
Condensed Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands | Total | Share Capital | Additional Paid in Capital | Treasury Shares | Accumulated Deficit | Accumulated Other Comprehensive Loss |
Beginning balance at Dec. 31, 2020 | $ 63,387 | $ 3 | $ 109,837 | $ (1,090) | $ (44,799) | $ (564) |
Beginning balance, shares at Dec. 31, 2020 | 26,035,000 | |||||
Ending balance at Jun. 30, 2021 | 100,178 | $ 3 | 117,521 | (3,276) | (13,422) | (648) |
Ending balance, shares at Jun. 30, 2021 | 26,503,000 | |||||
Beginning balance at Dec. 31, 2020 | 63,387 | $ 3 | 109,837 | (1,090) | (44,799) | (564) |
Beginning balance, shares at Dec. 31, 2020 | 26,035,000 | |||||
Net income | 35,994 | 35,994 | ||||
Share-based compensation | 5,061 | 5,061 | ||||
Issuance of ordinary shares under ESPP | 1,164 | 1,164 | ||||
Issuance of ordinary shares under ESPP, shares | 39,000 | |||||
Issuance of vested shares | 195,000 | |||||
Treasury shares withheld for net settlement | (2,573) | (2,573) | ||||
Treasury shares withheld for net settlement, shares | (55,000) | |||||
Share options exercised | 4,541 | 4,541 | ||||
Share options exercised, shares | 425,000 | |||||
Foreign currency translation | (122) | (122) | ||||
Ending balance at Sep. 30, 2021 | 107,452 | $ 3 | 120,603 | (3,663) | (8,805) | (686) |
Ending balance, shares at Sep. 30, 2021 | 26,639,000 | |||||
Beginning balance at Jun. 30, 2021 | 100,178 | $ 3 | 117,521 | (3,276) | (13,422) | (648) |
Beginning balance, shares at Jun. 30, 2021 | 26,503,000 | |||||
Net income | 4,617 | 4,617 | ||||
Share-based compensation | 1,886 | 1,886 | ||||
Issuance of vested shares | 34,000 | |||||
Treasury shares withheld for net settlement | (387) | (387) | ||||
Treasury shares withheld for net settlement, shares | (11,000) | |||||
Share options exercised | 1,196 | 1,196 | ||||
Share options exercised, shares | 113,000 | |||||
Foreign currency translation | (38) | (38) | ||||
Ending balance at Sep. 30, 2021 | 107,452 | $ 3 | 120,603 | (3,663) | (8,805) | (686) |
Ending balance, shares at Sep. 30, 2021 | 26,639,000 | |||||
Beginning balance at Dec. 31, 2021 | 112,137 | $ 3 | 124,117 | (3,906) | (7,378) | (699) |
Beginning balance, shares at Dec. 31, 2021 | 26,735,175 | |||||
Ending balance at Jun. 30, 2022 | 118,152 | $ 3 | 130,430 | (4,512) | (6,624) | (1,145) |
Ending balance, shares at Jun. 30, 2022 | 26,964,000 | |||||
Beginning balance at Dec. 31, 2021 | 112,137 | $ 3 | 124,117 | (3,906) | (7,378) | (699) |
Beginning balance, shares at Dec. 31, 2021 | 26,735,175 | |||||
Net income | 10,189 | 10,189 | ||||
Share-based compensation | 7,073 | 7,073 | ||||
Issuance of ordinary shares under ESPP | 1,606 | 1,606 | ||||
Issuance of ordinary shares under ESPP, shares | 87,229 | |||||
Issuance of vested shares | 192,690 | |||||
Treasury shares withheld for net settlement | (817) | (817) | ||||
Treasury shares withheld for net settlement, shares | (43,109) | |||||
Share options exercised | $ 362 | 362 | ||||
Share options exercised, shares | 44,119 | 44,119 | ||||
Foreign currency translation | $ (729) | (729) | ||||
Ending balance at Sep. 30, 2022 | 129,821 | $ 3 | 133,158 | (4,723) | 2,811 | (1,428) |
Ending balance, shares at Sep. 30, 2022 | 27,016,104 | |||||
Beginning balance at Jun. 30, 2022 | 118,152 | $ 3 | 130,430 | (4,512) | (6,624) | (1,145) |
Beginning balance, shares at Jun. 30, 2022 | 26,964,000 | |||||
Net income | 9,435 | 9,435 | ||||
Share-based compensation | 2,615 | 2,615 | ||||
Issuance of vested shares | 47,000 | |||||
Treasury shares withheld for net settlement | (211) | (211) | ||||
Treasury shares withheld for net settlement, shares | (12,000) | |||||
Share options exercised | 113 | 113 | ||||
Share options exercised, shares | 17,000 | |||||
Foreign currency translation | (283) | (283) | ||||
Ending balance at Sep. 30, 2022 | $ 129,821 | $ 3 | $ 133,158 | $ (4,723) | $ 2,811 | $ (1,428) |
Ending balance, shares at Sep. 30, 2022 | 27,016,104 |
Condensed Consolidated Statem_5
Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands | 9 Months Ended | |
Sep. 30, 2022 | Sep. 30, 2021 | |
Cash flows from operating activities: | ||
Net income | $ 10,189 | $ 35,994 |
Adjustments to reconcile net income to net cash provided by (used in) operating activities: | ||
Depreciation | 2,874 | 2,526 |
Amortization of software and intangible assets | 2,750 | 2,720 |
Amortization of debt issuance costs | 229 | 663 |
Share-based compensation | 7,785 | 5,584 |
Deferred income taxes | (1,987) | (6,424) |
Provision for inventory excess and obsolescence | 1,719 | (684) |
Other | (94) | (176) |
Change in assets and liabilities: | ||
Receivables | (9,436) | (12,489) |
Inventories | (18,583) | 5,857 |
Prepaid expenses | 4,054 | (1,103) |
Accounts payable | (347) | (7,110) |
Accrued employee compensation | (10,159) | (1,786) |
Accrued liabilities | 286 | (128) |
Other assets and liabilities | 3,640 | 951 |
Net cash provided by (used in) operating activities | (7,080) | 24,395 |
Cash flows from investing activities: | ||
Purchase of property and equipment | (3,242) | (4,197) |
Purchase of software | (3,441) | (2,591) |
Net cash used in investing activities | (6,683) | (6,788) |
Cash flows from financing activities: | ||
Repayment of term loan | (1,312) | (24,572) |
Issuance of ordinary shares under ESPP | 1,127 | 833 |
Taxes paid from shares withheld | (760) | (2,254) |
Proceeds from share option exercises | 362 | 4,541 |
Net cash used in financing activities | (583) | (21,452) |
Effect of exchange rate on cash | (86) | (31) |
Net decrease in cash | (14,432) | (3,876) |
Cash, beginning of period | 59,291 | 62,472 |
Cash, end of period | 44,859 | 58,596 |
Supplemental disclosure of cash flow information: | ||
Income taxes paid | 908 | 573 |
Interest paid | $ 497 | $ 1,828 |
Business and Significant Accoun
Business and Significant Accounting Policies | 9 Months Ended |
Sep. 30, 2022 | |
Accounting Policies [Abstract] | |
Business and significant accounting policies | Note 1. Business and significant accounting policies Business Cambium Networks Corporation (“Cambium” or “Cambium Networks” or the “Company”), incorporated under the laws of the Cayman Islands, is a holding company whose principal operating entities are Cambium Networks, Ltd. (UK), Cambium Networks, Inc. (USA), and Cambium Networks Private Limited (India). On October 28, 2011, Cambium acquired the point-to-point (“PTP”) and point-to-multi-point (“PMP”) businesses from Motorola Solutions, Inc. in an acquisition funded by investment funds affiliated with Vector Capital and Cambium Networks became the renamed entity subsequent to the acquisition. Cambium Networks completed an initial public offering of its ordinary shares and listed its ordinary shares on The NASDAQ Global Market in June 2019. Cambium Networks Corporation and its wholly owned subsidiaries provide fixed wireless broadband and enterprise solutions that work for businesses, communities and cities worldwide. Cambium Networks’ radios are deployed to connect people, places and things with a unified wireless fabric that spans multiple standards and frequencies of fixed wireless and Wi-Fi, all managed centrally via the cloud. The Company’s solutions are deployed in networks by service providers, enterprises, industrial and government connectivity solutions in urban, suburban and rural environments. Basis of Presentation The unaudited condensed consolidated financial statements include the accounts of Cambium Networks Corporation and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated. The condensed consolidated financial statements as of September 30, 2022, and for the three-month and nine-month periods ended September 30, 2021 and 2022, and the related notes are unaudited. The unaudited condensed consolidated financial statements have been prepared on the same basis as the annual audited consolidated financial statements, and, in the opinion of management, reflect all adjustments, which comprise only normal recurring adjustments necessary to state fairly the Company’s financial position as of September 30, 2022 and results of operations for the three-month and nine-month periods ended September 30, 2021 and 2022 and cash flows for the nine-month periods ended September 30, 2021 and 2022. The condensed consolidated balance sheet as of December 31, 2021 has been derived from the audited financial statements at that date. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) have been condensed or omitted. The condensed consolidated financial statements contained herein should be read in conjunction with the consolidated financial statements and related notes thereto for the year ended December 31, 2021 included in the Company’s annual report on Form 10-K and filed with the SEC on February 24, 2022. The results of operations for the three-month and nine-month periods ended September 30, 2022 are not necessarily indicative of the operating results to be expected for the full year. Update to Significant Accounting Policies There have been no material changes to the Company’s significant accounting policies disclosed in the 2021 Form 10-K, Part II, Item 8. |
Balance Sheet Components
Balance Sheet Components | 9 Months Ended |
Sep. 30, 2022 | |
Balance Sheet Related Disclosures [Abstract] | |
Balance sheet components | Note 2 . Balance sheet components Inventories, net Inventories, net consisted of the following (in thousands): December 31, September 30, 2021 2022 (unaudited) Finished goods $ 31,991 $ 44,893 Raw materials 7,353 11,962 Gross inventory 39,344 56,855 Less: Excess and obsolete provision ( 5,567 ) ( 6,214 ) Inventories, net $ 33,777 $ 50,641 Accrued liabilities Accrued liabilities consisted of the following (in thousands): December 31, September 30, 2021 2022 (unaudited) Accrued goods and services $ 12,278 $ 12,880 Accrued inventory purchases 2,218 2,053 Accrued customer rebates 7,355 12,065 Other 97 314 Accrued liabilities $ 21,948 $ 27,312 Accrued warranty Provisions for warranty claims are primarily related to our hardware products and are recorded at the time products are sold. The change to accrued warranty was as follows (in thousands): Year ended Nine months ended 2021 2022 (unaudited) Beginning balance $ 1,714 $ 1,731 Fulfillment of assumed acquisition warranty ( 216 ) ( 53 ) Provision increase (decrease), net 233 7 Ending balance $ 1,731 $ 1,685 At September 30, 2022, $ 1.2 million is included in Other current liabilities and $ 0.5 million is included in Other noncurrent liabilities on the Company’s condensed consolidated balance sheet. |
Property and Equipment
Property and Equipment | 9 Months Ended |
Sep. 30, 2022 | |
Property, Plant and Equipment [Abstract] | |
Property and equipment | Note 3 . Property and equipment Property and equipment, net consisted of the following (in thousands): December 31, September 30, Useful Life 2021 2022 (unaudited) Equipment and tooling 3 to 5 years $ 29,621 $ 32,097 Computer equipment 3 to 5 years 3,835 4,438 Furniture and fixtures 10 years 844 823 Leasehold improvements 2 to 3 years 457 475 Total cost 34,757 37,833 Less: Accumulated depreciation ( 24,267 ) ( 26,779 ) Property and equipment, net $ 10,490 $ 11,054 Total depreciation expense was $ 0.8 million and $ 1.0 million for the three-month periods ended September 30, 2021 and 2022, respectively and $ 2.5 million and $ 2.9 million for the nine-month period ended September 30, 2021 and 2022, respectively. |
Software
Software | 9 Months Ended |
Sep. 30, 2022 | |
Research and Development [Abstract] | |
Software | Note 4 . Software Software consisted of the following (in thousands): December 31, 2021 September 30, 2022 Useful Gross carrying Accumulated Net balance Gross carrying Accumulated Net balance (unaudited) (unaudited) (unaudited) Acquired and 3 to 7 years $ 15,855 $ ( 14,907 ) $ 948 $ 15,884 $ ( 15,272 ) $ 612 Software marketed for 3 years 7,164 ( 2,245 ) 4,919 10,543 ( 3,383 ) 7,160 Total $ 23,019 $ ( 17,152 ) $ 5,867 $ 26,427 $ ( 18,655 ) $ 7,772 Amortization of acquired and internal use software is computed using the straight-line method over an estimated useful life of generally three to seven years . Amortization expense recognized on acquired and internal use software is reflected in depreciation and amortization in the condensed consolidated statements of operations. Amortization expense was $ 0.1 million and $ 0.1 million for the three-month periods ended September 30, 2021 and 2022, respectively, and $ 0.5 million and $ 0.4 million for the nine-month periods ended September 30, 2021 and 2022, respectively. Amortization expense recognized on software to be sold or marketed externally was $ 0.2 million and $ 0.4 million for the three-month periods ended September 30, 2021 and 2022, respectively, and $ 0.5 million and $ 1.1 million for the nine-month periods ended September 30, 2021 and 2022, respectively, and is included in cost of revenues on the condensed consolidated statements of operations. Based on capitalized software assets at September 30, 2022, estimated amortization expense in future fiscal years is as follows (unaudited and in thousands): Year ending December 31, Acquired and internal use software Software Total 2022 (October - December) $ 80 $ 442 $ 522 2023 244 2,749 2,993 2024 130 2,400 2,530 2025 82 1,436 1,518 2026 70 133 203 Thereafter 6 — 6 Total amortization $ 612 $ 7,160 $ 7,772 |
Goodwill and Intangible Assets
Goodwill and Intangible Assets | 9 Months Ended |
Sep. 30, 2022 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Goodwill and intangible assets | Note 5 . Goodwill and Intangible Assets When the Company acquired the trade assets of Motorola Solutions, Inc.’s wireless point-to-point and point-to-multi-point businesses in 2011, the transaction generated goodwill and certain intangible assets. The goodwill associated with this transaction was recorded by Cambium Networks Corporation and allocated to Cambium Networks, Ltd. and Cambium Networks, Inc. using a revenue and asset allocation method. Although goodwill has been allocated to two operating subsidiaries, the Company operates as one operating segment and one reporting unit and therefore, goodwill is reported, and impairment testing performed, at the Cambium Networks Corporation consolidated level. There was no change in the carrying amount of goodwill during the three-month period ended September 30, 2022 (unaudited). The Company tests goodwill and intangible assets for impairment annually on December 31 and more frequently if impairment indicators exist. Accordingly, the Company performs quarterly qualitative assessments of significant events and circumstances such as a reporting unit’s historical and current results, assumptions regarding future performance, strategic initiatives and overall economic factors, including the impact of the current global outbreak of the coronavirus (or COVID-19) and macro-economic developments, to determine the existence of potential indicators of impairment and assess if it is more likely than not that the fair value of the reporting unit or intangible asset is less than their carrying value. If indicators of impairment are identified, a quantitative impairment test is performed. Qualitative assessments for the quarter did not indicate the existence of impairment indicators. Based on the operating results for the nine-month period ended September 30, 2022 and other considerations, the Company believes that it is more likely than not that the enterprise value for its one reporting unit and the fair value of intangibles is still greater than their carrying values. Accordingly, no goodwill impairment indicators were present at September 30, 2022 that would necessitate an interim impairment assessment. The useful life, gross carrying value, accumulated amortization, and net balance for each major class of definite-lived intangible assets at each balance sheet date were as follows (in thousands): December 31, 2021 September 30, 2022 Useful Life Gross Accumulated Net balance Gross Accumulated Net balance (unaudited) (unaudited) (unaudited) Unpatented 3 - 7 years $ 14,660 $ ( 14,555 ) $ 105 $ 14,660 $ ( 14,660 ) $ — Customer 5 - 18 years 19,300 ( 8,628 ) 10,672 19,300 ( 9,752 ) 9,548 Patents 7 years 11,300 ( 11,300 ) — 11,300 ( 11,300 ) — Trademarks 10 years 5,270 ( 5,270 ) — 5,270 ( 5,270 ) — Total $ 50,530 $ ( 39,753 ) $ 10,777 $ 50,530 $ ( 40,982 ) $ 9,548 Intangible assets are amortized over their expected useful life and none are expected to have a significant residual value at the end of their useful life. Intangible assets amortization expense was $ 0.6 million and $ 0.4 million for the three-month periods ended September 30, 2021 and 2022, respectively, and $ 1.7 million and $ 1.2 million for the nine-month periods ended September 30, 2021 and 2022, respectively. Based on capitalized intangible assets as of September 30, 2022, estimated amortization expense amounts in future fiscal years are as follows (unaudited and in thousands): Year ending December 31, Amortization 2022 (October - December) $ 374 2023 1,498 2024 1,498 2025 1,498 2026 1,498 Thereafter 3,182 Total amortization $ 9,548 |
Debt
Debt | 9 Months Ended |
Sep. 30, 2022 | |
Debt Disclosure [Abstract] | |
Debt | Note 6 . Debt As of September 30, 2022, the Company had $ 28.7 million outstanding under its current term loan facility and $ 0.0 million outstanding under its revolving credit facility. The Company has available $ 45.0 million under its revolving credit facility (unaudited). The following table reflects the current and noncurrent portions of the external debt facilities at December 31, 2021 and September 30, 2022 (in thousands): December 31, September 30, 2021 2022 (unaudited) Term loan facility $ 30,000 $ 28,688 Less debt issuance costs ( 546 ) ( 443 ) Total debt 29,454 28,245 Less current portion of term facility ( 2,625 ) ( 3,281 ) Current portion of debt issuance costs 136 126 Total long-term external debt, net $ 26,965 $ 25,090 Secured credit agreement The Company is currently operating under its credit agreement entered into on November 17, 2021 with Bank of America ("BofA Credit Agreement") which provides for the provisions of loans and other financial accommodations in an aggregate principal amount of up to $ 75.0 million in the form of (i) a five-year term loan facility (the "Term Facility") in the amount of $ 30.0 million and (ii) a five-year revolving credit facility (the "Revolving Facility") in the amount of $ 45.0 million, including a $ 5.0 million sublimit for the issuance of letters of credit and a $ 5.0 million sublimit for swingline loans. On November 17, 2021, the Company borrowed $ 30.0 million as a Eurodollar Rate loan. Both the Term Facility and the Revolving Facility mature on November 17, 2026 . Interest accrues on the outstanding principal amount of the Term and Revolving Facilities on a quarterly basis and is equal to a base rate equal rate per annum determined by reference to the 1-month, 3-month or 6-month US Dollar LIBOR rate as selected by the Company, plus an applicable margin between 1.75 % to 2.25 % as determined by the Company’s performance as measured by the consolidated leverage ratio. At September 30, 2022, the applicable margin was 1.75 % and the effective interest rate on the term loan was 5.15 %. In addition to paying interest on the outstanding principal under the term loan facility, the Company is required to pay a quarterly commitment fee on the unutilized commitments under the revolving credit facility ranging from 0.20 % to 0.25 % as determined by the Company's performance as measured by the consolidated leverage ratio. The commitment fee was 0.20 % at September 30, 2022. The Company is also required to pay letter of credit fees on the maximum amount available to be drawn under all outstanding letters of credit in an amount equal to the applicable margin on LIBOR-based borrowings under the revolving credit facility on a per annum basis, payable in arrears, as well as fronting fees for the issuance of letters of credit and agency fees. Under the BofA Credit Agreement, commencing on March 31, 2022, the Company began making quarterly principal payments of $ 0.7 million, with the remaining principal due on maturity on November 17, 2026 . The Company is required to pay interest quarterly on the outstanding balance. The Company is permitted to voluntarily reduce the unutilized portion of the commitment amount and repay outstanding loans under the BofA Credit Agreement at any time without premium or penalty. Maturities on the external debt outstanding at September 30, 2022 is as follows (unaudited and in thousands): Year ending December 31, 2022 (October - December) $ 1,313 2023 2,625 2024 2,625 2025 2,625 2026 19,500 Total $ 28,688 Borrowings under the BofA Credit Agreement are secured by a first-priority lien on substantially all of the Company’s assets, the equity interests in certain of the Company’s subsidiaries, and any intercompany debt. The Credit Agreement contains certain customary affirmative and negative covenants that are usual and customary for companies with similar credit ratings. As of September 30, 2022, the Company was in compliance with all affirmative and negative covenants (unaudited). Net int erest expense, including bank charges and amortization of debt issuance costs on the external debt, was $ 0.7 million and $ 0.5 million for the three-month periods ended September 30, 2021 and 2022, respectively, and $ 3.2 million and $ 1.4 million for the nine-month periods ended September 30, 2021 and 2022, respectively. The nine-month period ended September 30, 2021 included $ 0.3 million of additional amortization of debt issuance costs associated with the excess cash flow payment of $ 19.6 million made in the second quarter of 2021. Expected Discontinuation of LIBOR In July 2017, the United Kingdom’s Financial Conduct Authority, or FCA, which regulates LIBOR, announced it will no longer compel banks to submit rates for the calculation of LIBOR after 2021. On December 31, 2021, the 1-week and 2-month US Dollar LIBOR ceased, but the remaining five US Dollar LIBOR tenors (overnight and 1-month, 3-month, 6-month and 12-month) will not cease until June 30, 2023 . The base interest rate on the Company’s BofA Credit Agreement may be determined by reference to the 1-month, 3-month or 6-month US Dollar LIBOR rate, as selected by the Company. The BofA Credit Agreement matures on November 17, 2026 , which is subsequent to the cessation of all tenors of the US Dollar LIBOR rate. The Company is evaluating the potential impact of the transition from LIBOR as an interest rate benchmark to other potential alternative reference rates, including SOFR. Eurodollar loans under the BofA Credit Agreement are currently indexed to the Eurodollar Rate (the rate equivalent to LIBOR). The BofA Credit Agreement contemplates the discontinuation of LIBOR and provides that a benchmark replacement rate shall be determined by reference to other applicate rates and additionally allows for the Company to switch to a Base Rate Loan, as defined in the BofA Credit Agreement. The Company will continue to actively assess the related opportunities and risks involved in this transition. |
Employee Benefit Plans
Employee Benefit Plans | 9 Months Ended |
Sep. 30, 2022 | |
Retirement Benefits [Abstract] | |
Employee benefit plans | Note 7 . Employee benefit plans The Company’s employee benefit plans currently consist of a retirement plan in the United States and a separate defined contribution plan in the UK. The Company does not offer any other postretirement benefit plans, such as retiree medical and dental benefits or deferred compensation agreements to its employees or officers. U.S. plan U.S. employees that satisfy certain eligibility requirements, including requirements related to age and length of service, are eligible to participate in the Cambium Networks, Inc. 401(k) Plan. The plan is intended to qualify as a tax-qualified 401(k) plan so that contributions to the 401(k) plan, and income earned on such contributions, are not taxable to participants until withdrawn or distributed from the 401(k) plan. Under the 401(k) plan, each employee is fully vested in his or her deferred salary contributions. Employee contributions are held and invested by the plan’s trustee as directed by participants. Under the Cambium Networks, Inc. 401(k) Plan, the Company matches 100 % of employee contributions to the 401(k) plan up to a maximum amount of 4 % of eligible wages, which matching contributions are subject to vesting in equal annual increments over two years of service. All contributions, including the Company match, are made in cash. Contributions made by the Company under the Cambium Networks, Inc. 401(k) Plan were $ 0.2 million and $ 0.2 million for the three-month periods ended September 30, 2021 and 2022, respectively, and $ 1.0 million and $ 1.2 million for the nine-month periods ended September 30, 2021 and 2022, respectively. UK plan UK employees who satisfy certain eligibility requirements are eligible to participate in the Cambium Networks Ltd. Stakeholder Pension Scheme, which is a qualified defined contribution plan. Employees are eligible to participate on the first of the month following receipt of their enrollment form, and eligible employees are automatically enrolled in the plan at a default employee contribution rate of 3 % of eligible compensation and a company contribution rate of 5 % of the employee’s basic salary. The Company contribution rate increases by 1 % for each additional 1% that the employee contributes up to a maximum of 7 %. Company matching contributions vest immediately and employees are always vested in their own contributions. All contributions, including the Company match, are made in cash and deposited in the participant’s account each pay period. The total contributed by the Company under this plan was $ 0.1 million and $ 0.1 million for the three-month periods ended September 30, 2021 and 2022, respectively, and $ 0.3 million and $ 0.3 million for the nine-month periods ended September 30, 2021 and 2022, respectively. |
Other Expense, Net
Other Expense, Net | 9 Months Ended |
Sep. 30, 2022 | |
Other Income and Expenses [Abstract] | |
Other expense (income), net | Note 8 . Other expense (income), net Net other expense (income) changed from expense of $ 0.1 million for the three-month period ended September 30, 2021 to expense of $ 0.2 million for the three-month period ended September 30, 2022. Net other expense (income) changed from expense of $ 0.2 million for the nine-month period ended September 30, 2021 to income of $ 0.1 million for the nine-month period ended September 30, 2022. Other expense (income), net represents foreign exchange gains and losses. |
Share-Based Compensation
Share-Based Compensation | 9 Months Ended |
Sep. 30, 2022 | |
Share-Based Payment Arrangement [Abstract] | |
Share-based compensation | Note 9 . Share-based compensation 2019 Share incentive plan In June 2019, the Company’s Board of Directors adopted, and its shareholders approved, the 2019 Share Incentive Plan (“2019 Plan”). The 2019 Plan provides for the grant of incentive share options, nonqualified share options, share appreciation rights, restricted share awards (“RSAs”), restricted share units (“RSUs”), other share-based awards and performance awards. The share reserve under the 2019 Plan is automatically increased on the first day of each fiscal year, beginning with the fiscal year ended December 31, 2020 and continuing until, and including, the fiscal year ending December 31, 2029. The number of shares added annually is equal to the lowest of 1,320,000 shares, 5 % of the number of the Company’s shares outstanding on the first day of such fiscal year, or an amount determined by the Board of Directors. On February 25, 2022, the Company registered 1,320,000 additional shares that may be issued under the 2019 Plan. The Company’s employees, officers, directors, consultants, and advisors are eligible to receive awards under the 2019 Plan. Incentive share options, however, may only be granted to its employees. The following table summarizes changes in the number of shares available for grant under the Company’s equity incentive plans during the nine-month period ended September 30, 2022 (unaudited): Number of shares Available for grant at December 31, 2021 1,853,240 Added to 2019 Share Incentive Plan 1,320,000 RSUs granted ( 402,546 ) Options granted ( 963,000 ) Shares withheld in settlement of taxes and/or exercise price 43,109 Expirations 8,799 Forfeitures 115,493 Available for grant at September 30, 2022 1,975,095 Share-based compensation The following table shows total share-based compensation expense for the three-month and nine-month periods ended September 30, 2021 and 2022 (unaudited and in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2021 2022 2021 2022 Cost of revenues $ 39 $ 56 $ 108 $ 163 Research and development 834 1,241 2,193 3,274 Sales and marketing 540 696 1,374 1,901 General and administrative 663 855 1,909 2,447 Total share-based compensation expense $ 2,076 $ 2,848 $ 5,584 $ 7,785 For the three-month periods ended September 30, 2021 and 2022, the Company recorded corresponding income tax benefits of $ 0.6 million and $ 0.3 million, respectively, and for the nine-month periods ended September 30, 2021 and 2022, the Company recorded corresponding tax benefits of $ 3.0 million and $ 0.8 million, respectively. As of September 30, 2022, the Company estimates the pre-tax unrecognized compensation expense of $ 25.0 million, net of estimated forfeitures, related to all unvested share-based awards, including share options and restricted share units will be recognized through the third quarter of 2026. The Company expects to satisfy the exercise of share options and future distributions of shares for restricted share units by issuing new ordinary shares that have been reserved under the 2019 Plan. The Company uses the Black-Scholes option pricing model to estimate the fair value of share options. The Company utilized a forfeiture rate of 8.2 % during the nine-month period ended September 30, 2022 for estimating the forfeitures of share options and restricted share units granted. Share options Share options typically have a contractual term of ten years from grant date and typically vest over a four-year period. The following is a summary of option activity for the Company’s share incentive plans for the nine-month period ended September 30, 2022 (unaudited): Options Weighted Weighted Aggregate Outstanding at December 31, 2021 2,797,992 $ 12.64 7.9 $ 38,295,799 Options granted 963,000 $ 15.61 — $ — Options exercised ( 44,119 ) $ 8.20 — $ — Options expired ( 8,799 ) $ 14.77 — $ — Options forfeited ( 85,958 ) $ 8.53 — $ — Outstanding at September 30, 2022 3,622,116 $ 13.58 7.6 $ 15,206,759 Options exercisable at September 30, 2022 1,833,090 $ 12.10 6.5 $ 9,925,892 Options vested and expected to vest at September 30, 2022 3,547,231 $ 13.56 7.5 $ 14,940,070 At September 30, 2022, the aggregate intrinsic value of options exercisable under the Company’s share incentive plans was $ 9.9 million. The Company had 44,119 options exercised during the nine-month period ended September 30, 2022. At September 30, 2022, there was $ 13.7 million in unrecognized pre-tax share-based compensation expense, net of estimated forfeitures, related to unvested share option awards. The unrecognized share-based compensation expense is expected to be recognized through the third quarter of 2026. The fair value of options granted are estimated on the date of grant using the Black-Scholes option pricing model. The fair value of share options is being amortized on a straight-line basis over the requisite service period of the awards. The fair value of share options is estimated using the following weighted-average assumptions (unaudited): Nine Months Ended September 30, 2021 2022 Expected dividend yield — — Risk-free interest rate 1.14 % 2.96 % Weighted-average expected volatility 50.9 % 72.9 % Expected term (in years) 6.5 5.5 Weighted average grant-date fair value per share of options granted $ 21.36 $ 9.94 Restricted shares Restricted shares typically vest over a four-year period. The following is a summary of restricted shares activity for the Company’s share incentive plan for the nine-month period ended September 30, 2022 (unaudited): Units Weighted RSU balance at December 31, 2021 547,343 $ 22.47 RSUs granted 402,546 $ 15.14 RSUs vested ( 192,690 ) $ 22.99 RSUs forfeited ( 29,535 ) $ 23.70 RSU balance at September 30, 2022 727,664 $ 18.23 During the nine-month period ended September 30, 2022, 402,546 RSUs were granted under the Company’s 2019 Share Incentive Plan and 192,690 RSUs vested. The Company withheld 43,109 of those shares to pay the employees’ portion of the minimum payroll withholding taxes. As of September 30, 2022, there was $ 11.3 million in unrecognized pre-tax compensation expense, net of estimated forfeitures, related to unvested restricted share units. The unrecognized compensation expense is expected to be recognized through the third quarter of 2026. Employee share purchase plan In June 2019, the Company’s Board of Directors adopted, and its shareholders approved, the Employee Share Purchase Plan (“ESPP”). The ESPP was effective on June 25, 2019, and the initial offering period of six-months commenced on January 1, 2021. The current offering period of six months commenced on July 1, 2022 and runs through December 31, 2022. The purchase price of the shares is 85 % of the lower of the fair market value of the Company’s ordinary shares on the first trading day of the offering period and the purchase date. The ESPP includes an annual increase to the shares available for sale on the first day of each fiscal year beginning in 2020, equal to the lesser of: 275,000 shares, 1 % of the outstanding shares as of the last day of the immediately preceding fiscal year, or such other amount as the administrator may determine. The Company registered 267,352 additional shares on February 25, 2022. For the three-month periods ended September 30, 2021 and 2022, the Company recognized $ 0.2 million and $ 0.2 million, respectively, of share-based compensation expense related to the ESPP. For the nine-month periods ended September 30, 2021 and 2022, the Company recognized $ 0.5 million and $ 0.7 million, respectively, of share-based compensation expense related to the ESPP. There were 39,061 shares issued under the ESPP during the six-month offering period that ended on June 30, 2021 and 87,229 shares issued under the ESPP during the six-month offering period that ended on June 30, 2022. |
Share Capital - Shares
Share Capital - Shares | 9 Months Ended |
Sep. 30, 2022 | |
Stockholders' Equity Note [Abstract] | |
Share capital - shares | Note 10. Share capital - shares The following table reflects the share capital activity (unaudited): Number of Par value Balance at December 31, 2021 26,735,175 $ 3 Issuance of ordinary shares under employee share purchase plan 87,229 — Issuance of vested shares 192,690 — Share options exercised 44,119 — Shares withheld for net settlement of shares issued ( 43,109 ) — Balance at September 30, 2022 27,016,104 $ 3 As of September 30, 2022, no dividends have been declared or paid. |
Earnings Per Share
Earnings Per Share | 9 Months Ended |
Sep. 30, 2022 | |
Earnings Per Share [Abstract] | |
Earnings per share | Note 11. Earnings per share Basic net earnings per share is computed by dividing net income by the weighted-average number of shares outstanding during the period. Diluted net earnings per share is computed by giving effect to all potentially dilutive ordinary share equivalents outstanding for the period. For purposes of this calculation, share options, RSUs, RSAs, and ESPP awards are considered to be ordinary share equivalents but are excluded from the calculation of diluted earnings per share when including them would have an anti-dilutive effect. The following table sets forth the computation of basic and diluted net earnings per share (unaudited and in thousands, except for share and per share data): Three Months Ended September 30, Nine Months Ended September 30, 2021 2022 2021 2022 Numerator: Net income $ 4,617 $ 9,435 $ 35,994 $ 10,189 Denominator: Basic weighted average shares outstanding 26,540,843 26,977,155 26,342,113 26,855,395 Dilutive effect of share option awards 1,785,873 755,196 1,968,804 840,828 Dilutive effect of restricted share units and restricted share awards 312,459 242,443 382,951 235,509 Dilutive effect of employee share purchase plan 2 4,781 11,809 7,996 Diluted weighted average shares outstanding 28,639,177 27,979,575 28,705,677 27,939,728 Net earnings per share, basic $ 0.17 $ 0.35 $ 1.37 $ 0.38 Net earnings per share, diluted $ 0.16 $ 0.34 $ 1.25 $ 0.36 |
Income Taxes
Income Taxes | 9 Months Ended |
Sep. 30, 2022 | |
Income Tax Disclosure [Abstract] | |
Income taxes | Note 12. Income taxes The Company’s provision for income taxes is based upon the estimated annual tax rate for the year applied to federal, state and foreign income. The Company recorded a provision for income taxes of $ 0.4 million and a benefit for income taxes of $ 0.2 million for the three-month periods ended September 30, 2021 and 2022, with an effective tax rate of 7.1 % and ( 1.7 )%, respectively. In the three-month period ended September 30, 2021, the effective tax rate of 7.1 % was different from the statutory rate of 21.0 %, primarily due to tax benefits arising on employee restricted share vesting and option exercises. For the three-month period ended September 30, 2022, the Company’s effective tax rate of ( 1.7 )% was different from the statutory rate of 21.0 %, primarily due to Foreign Derived Intangible Income, tax benefits arising on Research and Development tax credits, and changes to excess tax benefits on share-based compensation. In the nine-month periods ended September 30, 2021 and 2022, the Company recorded a tax benefit of $ 5.9 million and $ 1.0 million, respectively, with an effective income tax rate of ( 19.6 )% and ( 11.5 )%, respectively. For the nine-month period ended September 30, 2021 the effective income tax rate of ( 19.6 )% was different from the statutory rate of 21 %, primarily due to the release of a valuation allowance against the loss carryforwards in the Company’s UK entity and tax benefits arising on employee restricted share vesting and option exercises. For the nine-month period ended September 30, 2022, the effective income tax rate of ( 11.5 )% was different from the statutory rate of 21 %, primarily due to tax benefits arising on Research and Development tax credits, Foreign Derived Intangible Income, the revaluing of certain UK deferred tax assets at a higher future tax rate, and changes to excess tax benefits on share-based compensation. The Company reviews the likelihood that it will realize the benefit of its deferred tax assets and, therefore, the need for a valuation allowance on a quarterly basis. In the first quarter of 2021, management concluded that all of the valuation allowance on the Company’s UK entity’s deferred tax assets was no longer needed. This was primarily due to a 12-quarter cumulative income through the first quarter of 2021 and the forecast of future taxable income. Accordingly, management recognized in 2021 a non-recurring tax benefit of $ 7.7 million related to the valuation allowance reversal. As of September 30, 2022, the Company continues to believe it is more likely than not that the net deferred tax assets will be realized by its UK entity. |
Commitments and Contingencies
Commitments and Contingencies | 9 Months Ended |
Sep. 30, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and contingencies | Note 13. Commitments and contingencies In accordance with ASC 460, Guarantees , the Company recognizes the fair value for guarantee and indemnification arrangements it issues or modifies, if these arrangements are within the scope of the interpretation. In addition, the Company must continue to monitor the conditions that are subject to the guarantees and indemnifications in order to identify if a loss has incurred. If the Company determines it is probable that a loss has occurred, then any such estimated loss would be recognized under those guarantees and indemnifications and would be recognized in the Company’s condensed consolidated statements of operations and corresponding condensed consolidated balance sheets during that period. Indemnification The Company generally indemnifies its customers against claims brought by a third party to the extent any such claim alleges that the Company’s product infringes a patent, copyright or trademark or violates any other proprietary rights of that third party. The maximum potential amount of future payments the Company may be required to make under these indemnification agreements is not estimable. The Company indemnifies its directors and officers and select key employees, including key employees serving as directors or officers of the Company’s subsidiaries, for certain events or occurrences, subject to certain limits, while the director or officer is or was serving at the Company’s request in such capacity. The term of the indemnification period is for the director’s or officer’s term of service. The Company may terminate the indemnification agreements with its directors, officers or key employees upon the termination of their services as directors or officers of the Company or its subsidiaries, or the termination of activities for which indemnification has been provided, but termination will not affect claims for indemnification related to events occurring prior to the effective date of termination. The maximum amount of potential future indemnification is unlimited; however, the Company has a director and officer insurance policy that limits its exposure. The Company believes the fair value of these indemnification agreements is minimal. Purchase commitments with contract manufacturers and suppliers We purchase components from a variety of suppliers and use contract manufacturers to provide manufacturing services for our products. During the normal course of business, in order to manage manufacturing lead times and help ensure adequate component supply, we enter into agreements with contract manufacturers and suppliers that allow them to procure inventory based upon criteria as defined by us, such as forecasted demand. The Company may be liable to purchase excess product or aged material from our suppliers following reasonable mitigation efforts. Warranties The Company offers a standard warranty on its products, with the term depending on the product, and records a liability for the estimated future costs associated with potential warranty claims. The Company’s responsibility under its standard warranty is the repair or replacement of in-warranty defective product, or to credit the purchase price of the defective product, at its discretion, without charge to the customer. The Company’s estimate of future warranty costs is largely based on historical experience factors including product failure rates, material usage, and service delivery cost incurred in correcting product failures. The standard warranty is included in either Other current liabilities or Other noncurrent liabilities on its condensed consolidated balance sheets, depending on the time period covered by the warranty. The Company also offers an extended warranty for purchase that represents a future performance obligation for the Company. The extended warranty is included in deferred revenues (both current and noncurrent) on the condensed consolidated balance sheets and recognized on a straight-line basis over the term of the extended warranty. The warranty costs are reflected in the Company’s condensed consolidated statements of operations within cost of revenues. Legal proceedings Third parties may from time to time assert legal claims against the Company. The Company records accruals for loss contingencies to the extent that it concludes it is probable that a liability has been incurred and the amount of the related loss can be reasonably estimated. The Company evaluates, on a regular basis, developments in legal proceedings and other matters that could cause a change in amounts recorded. Due to the inherent uncertainty involving legal matters, the ultimate resolution could differ from amounts recorded. There is no pending or threatened legal proceedings to which the Company is a party, that in the Company’s opinion, is likely to have a material adverse effect on its financial condition or results of operations. |
Segment Information
Segment Information | 9 Months Ended |
Sep. 30, 2022 | |
Segment Reporting [Abstract] | |
Segment information | Note 14. Segment information The Company’s chief operating decision maker (“CODM”) is its Chief Executive Officer. The Company’s CODM reviews financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance. Accordingly, the Company determined that it operates as one operating segment and one reporting unit. |
Revenues from Contracts with Cu
Revenues from Contracts with Customers | 9 Months Ended |
Sep. 30, 2022 | |
Revenue from Contract with Customer [Abstract] | |
Revenues from contracts with customers | Note 15. Revenues from contracts with customers Revenues consist primarily of revenues from the sale of hardware products with essential embedded software. Revenues also include limited amounts for software products, extended warranty on hardware products and subscription services. Substantially all products are sold through distributors and other channel partners, such as resellers and systems integrators. The Company recognizes revenue to reflect the transfer of control of promised products or services to a customer in an amount that reflects the consideration to which the Company expects to be entitled in exchange for products or services. The Company accounts for a contract when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable. The Company identifies its distinct performance obligations under each contract. A performance obligation is a promise in a contract to transfer a distinct product or service to the customer. Hardware products with essential embedded software, software products, and purchased extended warranty on hardware products have been identified as separate and distinct performance obligations. The transaction price is the amount of consideration to which the Company expects to be entitled in exchange for transferring products or services to a customer. An adjustment to revenue is made to adjust the transaction price to exclude the consideration related to products expected to be returned. The Company records an asset at the carrying amount of the estimated stock returns and a liability for the estimated amount expected to be refunded to the customer. The transaction price also excludes other forms of consideration provided to the customer, such as volume-based rebates and co-operative marketing allowances. The Company recognizes revenue when, or as, it satisfies a performance obligation by transferring control of a promised product or service to a customer. Revenue from hardware products with essential embedded software is recognized when control of the asset is transferred, which is typically at the time of shipment. Revenue from perpetual license software is recognized at the point in time that the customer is able to use or benefit from the software. Extended warranty on hardware products is a performance obligation that is satisfied over time, beginning on the effective date of the warranty period and ending on the expiration of the warranty period. The Company recognizes revenue on extended warranties on a straight-line basis over the warranty period. Revenue from software subscriptions is recognized ratably over the term in which the services are provided and the performance obligation is satisfied. The Company enters into revenue arrangements that may consist of multiple performance obligations, such as hardware products and extended warranty. The Company allocates the transaction price to each performance obligation on a relative standalone selling price basis for each distinct product or service in the contract. The best evidence of standalone selling price is the observable price of a product or service when the Company sells that product or service separately in similar circumstances and to similar customers. If a standalone selling price is not directly observable, the Company estimates the transaction price allocated to each performance obligation using the expected costs plus a margin approach. Disaggregation of revenues Revenues by product category were as follows (unaudited and in thousands, except percentages): Three Months Ended September 30, Nine Months Ended September 30, 2021 2022 2021 2022 Point-to-Multi-Point $ 50,144 66 % $ 26,090 32 % $ 167,739 65 % $ 85,285 40 % Point-to-Point 13,890 18 % 15,409 19 % 45,432 18 % 45,807 21 % Enterprise 10,734 14 % 38,330 47 % 41,154 16 % 77,852 37 % Other 1,152 2 % 1,371 2 % 2,819 1 % 3,448 2 % Total Revenues $ 75,920 100 % $ 81,200 100 % $ 257,144 100 % $ 212,392 100 % In the above table, the Company has renamed the Wi-Fi product category to Enterprise to more accurately represent the products and services included in this product category, which includes Wi-Fi, switching and software subscriptions. The Company’s products are predominately sold through third-party distributors, and distributed through a third-party logistics provider with facilities in the United States, Netherlands and China. The Company has determined the geographical distribution of product revenues based upon the ship-to destinations specified by its distributor customers. Revenues by geography were as follows (unaudited and in thousands, except percentages): Three Months Ended September 30, Nine Months Ended September 30, 2021 2022 2021 2022 North America $ 36,564 48 % $ 30,086 37 % $ 140,105 54 % $ 89,547 42 % Europe, Middle East and Africa 23,414 31 % 29,263 36 % 67,047 26 % 70,876 34 % Caribbean and Latin America 7,993 11 % 8,935 11 % 30,660 12 % 21,979 10 % Asia Pacific 7,949 10 % 12,916 16 % 19,332 8 % 29,990 14 % Total Revenues $ 75,920 100 % $ 81,200 100 % $ 257,144 100 % $ 212,392 100 % Contract balances The following table summarizes contract balances as of December 31, 2021 and September 30, 2022 (in thousands): December 31, September 30, (unaudited) Trade accounts receivable, net of allowance for $ 68,788 $ 83,679 Deferred revenue - current 6,880 8,226 Deferred revenue - noncurrent 5,363 8,201 Refund liability $ 2,516 $ 3,051 Deferred revenue consists of amounts due or received from customers in advance of the Company satisfying performance obligations under contractual arrangements. Deferred revenue is classified as current or noncurrent based on the timing of when revenue will be recognized. The changes in deferred revenue were due to normal timing differences between the Company’s performance and the customers’ payment. The refund liability is the estimated amount expected to be refunded to customers in relation to product exchanges made as part of the Company’s stock rotation program and returns that have been authorized, but not yet received by the Company. It is included within Other current liabilities in the condensed consolidated balance sheets. Receivables and concentration of credit risk Trade accounts receivable represents amounts for which the Company has an unconditional right to payment. Amounts are in accordance with contractual terms and are recorded at face amount less an allowance for credit losses. The Company establishes an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivables. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity indicators for individual customers. The Company considers the credit risk of all customers and regularly monitors credit risk exposure in its trade receivables. The Company’s standard credit terms with its customers are generally net 30 to 60 days . The Company had one customer representing more than 10 % of trade receivables at December 31, 2021 and one customer representing more than 10 % of trade receivables at September 30, 2022. Remaining performance obligations Remaining performance obligations represent the revenue that is expected to be recognized in future periods related to performance obligations included in a contract that are unsatisfied, or partially satisfied, as of the end of a period. As of December 31, 2021, deferred revenue (current and noncurrent) of $ 12.2 million represents the Company’s remaining performance obligations, of which $ 6.9 million is expected to be recognized within one year , with the remainder to be recognized thereafter. As of September 30, 2022, deferred revenue (current and noncurrent) of $ 16.4 million represents the Company’s remaining performance obligations, of which $ 8.2 million is expected to be recognized within one year , with the remainder to be recognized thereafter (unaudited). Revenue recognized during the three-month and nine-month periods ended September 30, 2022 which was previously included in deferred revenues as of December 31, 2021 was $ 1.5 million and $ 5.7 million, respectively, compared to $ 1.8 million and $ 5.4 million of revenue recognized during the three-month and nine-month periods ended September 30, 2021, respectively, which was previously included in deferred revenues as of December 31, 2020 (unaudited). Cost to obtain a contract Sales commissions are incremental costs of obtaining a contract. The Company has elected to recognize these expenses as incurred, as the amortization period of these costs is one year or less. |
Leases
Leases | 9 Months Ended |
Sep. 30, 2022 | |
Leases [Abstract] | |
Leases | Note 16. Leases The Company has operating leases for offices, vehicles and equipment. Leases with a term of 12 months or less are not recorded on the consolidated balance sheets and are expensed on a straight-line basis over the lease term. Right-of-use assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at the commencement date. The Company’s lease payments are typically fixed or contain fixed escalators. The Company’s leases typically include certain lock-in periods and renewal options to extend the lease, but does not consider options to extend the lease it is not reasonably certain to exercise. The Company elected the practical expedient to not separate the lease and non-lease components of its leases and currently has no leases with options to purchase the leased property. The components of lease expense were as follows and are included in general and administrative expense (unaudited and in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2021 2022 2021 2022 Operating lease cost $ 630 $ 580 $ 1,981 $ 1,781 Short-term lease cost 82 99 222 352 Variable lease costs 125 171 354 461 Total lease expense $ 837 $ 850 $ 2,557 $ 2,594 Supplemental balance sheet information related to leases were as follows (in thousands, except lease term and discount rate): Balance Sheet Caption December 31, 2021 September 30, 2022 (unaudited) Operating leases: Operating lease assets Operating lease assets $ 5,899 $ 4,548 Current lease liabilities Other current liabilities $ 2,116 $ 2,001 Noncurrent lease liabilities Noncurrent operating lease liabilities $ 4,112 $ 2,558 Weighted average remaining lease term (years): Operating leases 3.35 2.78 Weighted average discount rate: Operating leases 6.15 % 6.12 % Supplemental cash flow information related to leases were as follows (unaudited and in thousands): Nine Months Ended September 30, 2021 2022 Supplemental cash flow information: Cash paid for amounts included in the measurement $ 1,976 $ 1,783 The Company’s current lease terms range from one to four years and may include options to extend the lease by one to four years . Remaining maturities on lease liabilities as of September 30, 2022 is as follows (unaudited and in thousands): Operating leases 2022 (October - December) $ 611 2023 2,093 2024 1,086 2025 783 2026 374 Thereafter — Total lease payments 4,947 Less: interest 388 Present value of lease liabilities $ 4,559 As of September 30, 2022, the Company does not have any leases that have not yet commenced. |
Related Party Transactions
Related Party Transactions | 9 Months Ended |
Sep. 30, 2022 | |
Related Party Transactions [Abstract] | |
Related party transactions | Note 17. Related party transactions The Company follows ASC 850, Related Party Disclosures , for the identification of related parties and disclosure of related party transactions. A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal. For the three-month and nine-month periods ended September 30, 2021 and 2022, the Company did no t have any related party transactions to disclose (unaudited). |
Business and Significant Acco_2
Business and Significant Accounting Policies (Policies) | 9 Months Ended |
Sep. 30, 2022 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation The unaudited condensed consolidated financial statements include the accounts of Cambium Networks Corporation and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated. The condensed consolidated financial statements as of September 30, 2022, and for the three-month and nine-month periods ended September 30, 2021 and 2022, and the related notes are unaudited. The unaudited condensed consolidated financial statements have been prepared on the same basis as the annual audited consolidated financial statements, and, in the opinion of management, reflect all adjustments, which comprise only normal recurring adjustments necessary to state fairly the Company’s financial position as of September 30, 2022 and results of operations for the three-month and nine-month periods ended September 30, 2021 and 2022 and cash flows for the nine-month periods ended September 30, 2021 and 2022. The condensed consolidated balance sheet as of December 31, 2021 has been derived from the audited financial statements at that date. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) have been condensed or omitted. The condensed consolidated financial statements contained herein should be read in conjunction with the consolidated financial statements and related notes thereto for the year ended December 31, 2021 included in the Company’s annual report on Form 10-K and filed with the SEC on February 24, 2022. The results of operations for the three-month and nine-month periods ended September 30, 2022 are not necessarily indicative of the operating results to be expected for the full year. |
Update to Significant Accounting Policies | Update to Significant Accounting Policies There have been no material changes to the Company’s significant accounting policies disclosed in the 2021 Form 10-K, Part II, Item 8. |
Balance Sheet Components (Table
Balance Sheet Components (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Balance Sheet Related Disclosures [Abstract] | |
Schedule of Inventories, Net | Inventories, net consisted of the following (in thousands): December 31, September 30, 2021 2022 (unaudited) Finished goods $ 31,991 $ 44,893 Raw materials 7,353 11,962 Gross inventory 39,344 56,855 Less: Excess and obsolete provision ( 5,567 ) ( 6,214 ) Inventories, net $ 33,777 $ 50,641 |
Schedule of Accrued Liabilities | Accrued liabilities consisted of the following (in thousands): December 31, September 30, 2021 2022 (unaudited) Accrued goods and services $ 12,278 $ 12,880 Accrued inventory purchases 2,218 2,053 Accrued customer rebates 7,355 12,065 Other 97 314 Accrued liabilities $ 21,948 $ 27,312 |
Schedule of Change to Accrued Warranty | Provisions for warranty claims are primarily related to our hardware products and are recorded at the time products are sold. The change to accrued warranty was as follows (in thousands): Year ended Nine months ended 2021 2022 (unaudited) Beginning balance $ 1,714 $ 1,731 Fulfillment of assumed acquisition warranty ( 216 ) ( 53 ) Provision increase (decrease), net 233 7 Ending balance $ 1,731 $ 1,685 |
Property and Equipment (Tables)
Property and Equipment (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Property, Plant and Equipment [Abstract] | |
Schedule of Property and Equipment, Net | Property and equipment, net consisted of the following (in thousands): December 31, September 30, Useful Life 2021 2022 (unaudited) Equipment and tooling 3 to 5 years $ 29,621 $ 32,097 Computer equipment 3 to 5 years 3,835 4,438 Furniture and fixtures 10 years 844 823 Leasehold improvements 2 to 3 years 457 475 Total cost 34,757 37,833 Less: Accumulated depreciation ( 24,267 ) ( 26,779 ) Property and equipment, net $ 10,490 $ 11,054 |
Software (Tables)
Software (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Schedule of Carrying Amount and Amortization of Software and Intangible Assets | The useful life, gross carrying value, accumulated amortization, and net balance for each major class of definite-lived intangible assets at each balance sheet date were as follows (in thousands): December 31, 2021 September 30, 2022 Useful Life Gross Accumulated Net balance Gross Accumulated Net balance (unaudited) (unaudited) (unaudited) Unpatented 3 - 7 years $ 14,660 $ ( 14,555 ) $ 105 $ 14,660 $ ( 14,660 ) $ — Customer 5 - 18 years 19,300 ( 8,628 ) 10,672 19,300 ( 9,752 ) 9,548 Patents 7 years 11,300 ( 11,300 ) — 11,300 ( 11,300 ) — Trademarks 10 years 5,270 ( 5,270 ) — 5,270 ( 5,270 ) — Total $ 50,530 $ ( 39,753 ) $ 10,777 $ 50,530 $ ( 40,982 ) $ 9,548 |
Schedule of Estimated Amortization Expense of Capitalized Software and Intangible Assets | Based on capitalized intangible assets as of September 30, 2022, estimated amortization expense amounts in future fiscal years are as follows (unaudited and in thousands): Year ending December 31, Amortization 2022 (October - December) $ 374 2023 1,498 2024 1,498 2025 1,498 2026 1,498 Thereafter 3,182 Total amortization $ 9,548 |
Capitalized Software Assets | |
Schedule of Carrying Amount and Amortization of Software and Intangible Assets | Software consisted of the following (in thousands): December 31, 2021 September 30, 2022 Useful Gross carrying Accumulated Net balance Gross carrying Accumulated Net balance (unaudited) (unaudited) (unaudited) Acquired and 3 to 7 years $ 15,855 $ ( 14,907 ) $ 948 $ 15,884 $ ( 15,272 ) $ 612 Software marketed for 3 years 7,164 ( 2,245 ) 4,919 10,543 ( 3,383 ) 7,160 Total $ 23,019 $ ( 17,152 ) $ 5,867 $ 26,427 $ ( 18,655 ) $ 7,772 |
Schedule of Estimated Amortization Expense of Capitalized Software and Intangible Assets | Based on capitalized software assets at September 30, 2022, estimated amortization expense in future fiscal years is as follows (unaudited and in thousands): Year ending December 31, Acquired and internal use software Software Total 2022 (October - December) $ 80 $ 442 $ 522 2023 244 2,749 2,993 2024 130 2,400 2,530 2025 82 1,436 1,518 2026 70 133 203 Thereafter 6 — 6 Total amortization $ 612 $ 7,160 $ 7,772 |
Goodwill and Intangible Assets
Goodwill and Intangible Assets (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of Carrying Amount and Amortization of Software and Intangible Assets | The useful life, gross carrying value, accumulated amortization, and net balance for each major class of definite-lived intangible assets at each balance sheet date were as follows (in thousands): December 31, 2021 September 30, 2022 Useful Life Gross Accumulated Net balance Gross Accumulated Net balance (unaudited) (unaudited) (unaudited) Unpatented 3 - 7 years $ 14,660 $ ( 14,555 ) $ 105 $ 14,660 $ ( 14,660 ) $ — Customer 5 - 18 years 19,300 ( 8,628 ) 10,672 19,300 ( 9,752 ) 9,548 Patents 7 years 11,300 ( 11,300 ) — 11,300 ( 11,300 ) — Trademarks 10 years 5,270 ( 5,270 ) — 5,270 ( 5,270 ) — Total $ 50,530 $ ( 39,753 ) $ 10,777 $ 50,530 $ ( 40,982 ) $ 9,548 |
Schedule of Estimated Amortization Expense of Capitalized Software and Intangible Assets | Based on capitalized intangible assets as of September 30, 2022, estimated amortization expense amounts in future fiscal years are as follows (unaudited and in thousands): Year ending December 31, Amortization 2022 (October - December) $ 374 2023 1,498 2024 1,498 2025 1,498 2026 1,498 Thereafter 3,182 Total amortization $ 9,548 |
Debt (Tables)
Debt (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Debt Disclosure [Abstract] | |
Schedule of Current and Noncurrent Portions of External Debt Facilities | The following table reflects the current and noncurrent portions of the external debt facilities at December 31, 2021 and September 30, 2022 (in thousands): December 31, September 30, 2021 2022 (unaudited) Term loan facility $ 30,000 $ 28,688 Less debt issuance costs ( 546 ) ( 443 ) Total debt 29,454 28,245 Less current portion of term facility ( 2,625 ) ( 3,281 ) Current portion of debt issuance costs 136 126 Total long-term external debt, net $ 26,965 $ 25,090 |
Schedule of Maturities on External Debt Outstanding | Maturities on the external debt outstanding at September 30, 2022 is as follows (unaudited and in thousands): Year ending December 31, 2022 (October - December) $ 1,313 2023 2,625 2024 2,625 2025 2,625 2026 19,500 Total $ 28,688 |
Share-Based Compensation (Table
Share-Based Compensation (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Share-Based Payment Arrangement [Abstract] | |
Summary of Changes in Number of Shares Available for Grant | The following table summarizes changes in the number of shares available for grant under the Company’s equity incentive plans during the nine-month period ended September 30, 2022 (unaudited): Number of shares Available for grant at December 31, 2021 1,853,240 Added to 2019 Share Incentive Plan 1,320,000 RSUs granted ( 402,546 ) Options granted ( 963,000 ) Shares withheld in settlement of taxes and/or exercise price 43,109 Expirations 8,799 Forfeitures 115,493 Available for grant at September 30, 2022 1,975,095 |
Schedule of Total Share Based Compensation Expense | The following table shows total share-based compensation expense for the three-month and nine-month periods ended September 30, 2021 and 2022 (unaudited and in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2021 2022 2021 2022 Cost of revenues $ 39 $ 56 $ 108 $ 163 Research and development 834 1,241 2,193 3,274 Sales and marketing 540 696 1,374 1,901 General and administrative 663 855 1,909 2,447 Total share-based compensation expense $ 2,076 $ 2,848 $ 5,584 $ 7,785 |
Summary of Stock Option Activity | The following is a summary of option activity for the Company’s share incentive plans for the nine-month period ended September 30, 2022 (unaudited): Options Weighted Weighted Aggregate Outstanding at December 31, 2021 2,797,992 $ 12.64 7.9 $ 38,295,799 Options granted 963,000 $ 15.61 — $ — Options exercised ( 44,119 ) $ 8.20 — $ — Options expired ( 8,799 ) $ 14.77 — $ — Options forfeited ( 85,958 ) $ 8.53 — $ — Outstanding at September 30, 2022 3,622,116 $ 13.58 7.6 $ 15,206,759 Options exercisable at September 30, 2022 1,833,090 $ 12.10 6.5 $ 9,925,892 Options vested and expected to vest at September 30, 2022 3,547,231 $ 13.56 7.5 $ 14,940,070 |
Schedule of Estimated Fair Value of Weighted Average Assumptions | The fair value of options granted are estimated on the date of grant using the Black-Scholes option pricing model. The fair value of share options is being amortized on a straight-line basis over the requisite service period of the awards. The fair value of share options is estimated using the following weighted-average assumptions (unaudited): Nine Months Ended September 30, 2021 2022 Expected dividend yield — — Risk-free interest rate 1.14 % 2.96 % Weighted-average expected volatility 50.9 % 72.9 % Expected term (in years) 6.5 5.5 Weighted average grant-date fair value per share of options granted $ 21.36 $ 9.94 |
Summary of Restricted Shares Activity | The following is a summary of restricted shares activity for the Company’s share incentive plan for the nine-month period ended September 30, 2022 (unaudited): Units Weighted RSU balance at December 31, 2021 547,343 $ 22.47 RSUs granted 402,546 $ 15.14 RSUs vested ( 192,690 ) $ 22.99 RSUs forfeited ( 29,535 ) $ 23.70 RSU balance at September 30, 2022 727,664 $ 18.23 |
Share Capital - Shares (Tables)
Share Capital - Shares (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Stockholders' Equity Note [Abstract] | |
Shares (Share Capital Activity) | The following table reflects the share capital activity (unaudited): Number of Par value Balance at December 31, 2021 26,735,175 $ 3 Issuance of ordinary shares under employee share purchase plan 87,229 — Issuance of vested shares 192,690 — Share options exercised 44,119 — Shares withheld for net settlement of shares issued ( 43,109 ) — Balance at September 30, 2022 27,016,104 $ 3 |
Earnings Per Share (Tables)
Earnings Per Share (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Earnings Per Share [Abstract] | |
Schedule of Basic and Diluted Net Earnings Per Share | The following table sets forth the computation of basic and diluted net earnings per share (unaudited and in thousands, except for share and per share data): Three Months Ended September 30, Nine Months Ended September 30, 2021 2022 2021 2022 Numerator: Net income $ 4,617 $ 9,435 $ 35,994 $ 10,189 Denominator: Basic weighted average shares outstanding 26,540,843 26,977,155 26,342,113 26,855,395 Dilutive effect of share option awards 1,785,873 755,196 1,968,804 840,828 Dilutive effect of restricted share units and restricted share awards 312,459 242,443 382,951 235,509 Dilutive effect of employee share purchase plan 2 4,781 11,809 7,996 Diluted weighted average shares outstanding 28,639,177 27,979,575 28,705,677 27,939,728 Net earnings per share, basic $ 0.17 $ 0.35 $ 1.37 $ 0.38 Net earnings per share, diluted $ 0.16 $ 0.34 $ 1.25 $ 0.36 |
Revenues from Contracts with _2
Revenues from Contracts with Customers (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Revenue from Contract with Customer [Abstract] | |
Schedule of Revenues by Product Category | Revenues by product category were as follows (unaudited and in thousands, except percentages): Three Months Ended September 30, Nine Months Ended September 30, 2021 2022 2021 2022 Point-to-Multi-Point $ 50,144 66 % $ 26,090 32 % $ 167,739 65 % $ 85,285 40 % Point-to-Point 13,890 18 % 15,409 19 % 45,432 18 % 45,807 21 % Enterprise 10,734 14 % 38,330 47 % 41,154 16 % 77,852 37 % Other 1,152 2 % 1,371 2 % 2,819 1 % 3,448 2 % Total Revenues $ 75,920 100 % $ 81,200 100 % $ 257,144 100 % $ 212,392 100 % |
Schedule of Revenue by Geography | Revenues by geography were as follows (unaudited and in thousands, except percentages): Three Months Ended September 30, Nine Months Ended September 30, 2021 2022 2021 2022 North America $ 36,564 48 % $ 30,086 37 % $ 140,105 54 % $ 89,547 42 % Europe, Middle East and Africa 23,414 31 % 29,263 36 % 67,047 26 % 70,876 34 % Caribbean and Latin America 7,993 11 % 8,935 11 % 30,660 12 % 21,979 10 % Asia Pacific 7,949 10 % 12,916 16 % 19,332 8 % 29,990 14 % Total Revenues $ 75,920 100 % $ 81,200 100 % $ 257,144 100 % $ 212,392 100 % |
Summary of Contract Balances | The following table summarizes contract balances as of December 31, 2021 and September 30, 2022 (in thousands): December 31, September 30, (unaudited) Trade accounts receivable, net of allowance for $ 68,788 $ 83,679 Deferred revenue - current 6,880 8,226 Deferred revenue - noncurrent 5,363 8,201 Refund liability $ 2,516 $ 3,051 |
Leases (Tables)
Leases (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Leases [Abstract] | |
Components of Lease Expense | The components of lease expense were as follows and are included in general and administrative expense (unaudited and in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2021 2022 2021 2022 Operating lease cost $ 630 $ 580 $ 1,981 $ 1,781 Short-term lease cost 82 99 222 352 Variable lease costs 125 171 354 461 Total lease expense $ 837 $ 850 $ 2,557 $ 2,594 |
Supplemental Balance Sheet Information | Supplemental balance sheet information related to leases were as follows (in thousands, except lease term and discount rate): Balance Sheet Caption December 31, 2021 September 30, 2022 (unaudited) Operating leases: Operating lease assets Operating lease assets $ 5,899 $ 4,548 Current lease liabilities Other current liabilities $ 2,116 $ 2,001 Noncurrent lease liabilities Noncurrent operating lease liabilities $ 4,112 $ 2,558 Weighted average remaining lease term (years): Operating leases 3.35 2.78 Weighted average discount rate: Operating leases 6.15 % 6.12 % |
Supplemental Cash Flow Information | Supplemental cash flow information related to leases were as follows (unaudited and in thousands): Nine Months Ended September 30, 2021 2022 Supplemental cash flow information: Cash paid for amounts included in the measurement $ 1,976 $ 1,783 |
Remaining Maturities on Lease Liabilities | Remaining maturities on lease liabilities as of September 30, 2022 is as follows (unaudited and in thousands): Operating leases 2022 (October - December) $ 611 2023 2,093 2024 1,086 2025 783 2026 374 Thereafter — Total lease payments 4,947 Less: interest 388 Present value of lease liabilities $ 4,559 |
Balance Sheet Components - Sche
Balance Sheet Components - Schedule of Inventories, Net (Details) - USD ($) $ in Thousands | Sep. 30, 2022 | Dec. 31, 2021 |
Inventory, Net [Abstract] | ||
Finished goods | $ 44,893 | $ 31,991 |
Raw materials | 11,962 | 7,353 |
Gross inventory | 56,855 | 39,344 |
Less: Excess and obsolete provision | (6,214) | (5,567) |
Inventories, net | $ 50,641 | $ 33,777 |
Balance Sheet Components - Sc_2
Balance Sheet Components - Schedule of Accrued Liabilities (Details) - USD ($) $ in Thousands | Sep. 30, 2022 | Dec. 31, 2021 |
Accrued Liabilities, Current [Abstract] | ||
Accrued goods and services | $ 12,880 | $ 12,278 |
Accrued inventory purchases | 2,053 | 2,218 |
Accrued customer rebates | 12,065 | 7,355 |
Other | 314 | 97 |
Accrued liabilities | $ 27,312 | $ 21,948 |
Balance Sheet Components - Sc_3
Balance Sheet Components - Schedule of Change to Accrued Warranty (Details) - USD ($) $ in Thousands | 9 Months Ended | 12 Months Ended |
Sep. 30, 2022 | Dec. 31, 2021 | |
Standard Product Warranty Disclosure [Abstract] | ||
Beginning balance | $ 1,731 | $ 1,714 |
Fulfillment of assumed acquisition warranty | (53) | (216) |
Provision increase (decrease), net | (7) | 233 |
Ending balance | $ 1,685 | $ 1,731 |
Balance Sheet Components - Addi
Balance Sheet Components - Additional Information (Details) - USD ($) $ in Thousands | Sep. 30, 2022 | Dec. 31, 2021 | Dec. 31, 2020 |
Product Warranty Liability [Line Items] | |||
Accrued warranty | $ 1,685 | $ 1,731 | $ 1,714 |
Other Current Liabilities | |||
Product Warranty Liability [Line Items] | |||
Accrued warranty | 1,200 | ||
Other Noncurrent Liabilities | |||
Product Warranty Liability [Line Items] | |||
Accrued warranty | $ 500 |
Property and Equipment - Schedu
Property and Equipment - Schedule of Property and Equipment, Net (Details) - USD ($) $ in Thousands | 9 Months Ended | 12 Months Ended |
Sep. 30, 2022 | Dec. 31, 2021 | |
Property Plant And Equipment [Line Items] | ||
Total cost | $ 37,833 | $ 34,757 |
Less: Accumulated depreciation | (26,779) | (24,267) |
Property and equipment, net | 11,054 | 10,490 |
Equipment and Tooling | ||
Property Plant And Equipment [Line Items] | ||
Total cost | $ 32,097 | $ 29,621 |
Equipment and Tooling | Minimum | ||
Property Plant And Equipment [Line Items] | ||
Useful Life | 3 years | 3 years |
Equipment and Tooling | Maximum | ||
Property Plant And Equipment [Line Items] | ||
Useful Life | 5 years | 5 years |
Computer Equipment | ||
Property Plant And Equipment [Line Items] | ||
Total cost | $ 4,438 | $ 3,835 |
Computer Equipment | Minimum | ||
Property Plant And Equipment [Line Items] | ||
Useful Life | 3 years | 3 years |
Computer Equipment | Maximum | ||
Property Plant And Equipment [Line Items] | ||
Useful Life | 5 years | 5 years |
Furniture and Fixtures | ||
Property Plant And Equipment [Line Items] | ||
Useful Life | 10 years | 10 years |
Total cost | $ 823 | $ 844 |
Leasehold Improvements | ||
Property Plant And Equipment [Line Items] | ||
Total cost | $ 475 | $ 457 |
Leasehold Improvements | Minimum | ||
Property Plant And Equipment [Line Items] | ||
Useful Life | 2 years | 2 years |
Leasehold Improvements | Maximum | ||
Property Plant And Equipment [Line Items] | ||
Useful Life | 3 years | 3 years |
Property and Equipment - Additi
Property and Equipment - Additional Information (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Property, Plant and Equipment [Abstract] | ||||
Depreciation expense | $ 1,000 | $ 800 | $ 2,874 | $ 2,526 |
Software - Schedule of Software
Software - Schedule of Software (Details) - USD ($) $ in Thousands | 9 Months Ended | |
Sep. 30, 2022 | Dec. 31, 2021 | |
Finite Lived Intangible Assets [Line Items] | ||
Gross carrying amount | $ 26,427 | $ 23,019 |
Accumulated amortization | (18,655) | (17,152) |
Net balance | 7,772 | 5,867 |
Acquired and Software for Internal Use | ||
Finite Lived Intangible Assets [Line Items] | ||
Gross carrying amount | 15,884 | 15,855 |
Accumulated amortization | (15,272) | (14,907) |
Net balance | $ 612 | 948 |
Acquired and Software for Internal Use | Minimum | ||
Finite Lived Intangible Assets [Line Items] | ||
Useful Life | 3 years | |
Acquired and Software for Internal Use | Maximum | ||
Finite Lived Intangible Assets [Line Items] | ||
Useful Life | 7 years | |
Software Marketed for External Sale | ||
Finite Lived Intangible Assets [Line Items] | ||
Useful Life | 3 years | |
Gross carrying amount | $ 10,543 | 7,164 |
Accumulated amortization | (3,383) | (2,245) |
Net balance | $ 7,160 | $ 4,919 |
Software - Additional Informati
Software - Additional Information (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Acquired and Software for Internal Use | ||||
Finite Lived Intangible Assets [Line Items] | ||||
Amortization expense | $ 0.1 | $ 0.1 | $ 0.4 | $ 0.5 |
Acquired and Software for Internal Use | Minimum | ||||
Finite Lived Intangible Assets [Line Items] | ||||
Useful life | 3 years | |||
Acquired and Software for Internal Use | Maximum | ||||
Finite Lived Intangible Assets [Line Items] | ||||
Useful life | 7 years | |||
Software Marketed for External Sale | ||||
Finite Lived Intangible Assets [Line Items] | ||||
Useful life | 3 years | |||
Amortization expense | $ 0.4 | $ 0.2 | $ 1.1 | $ 0.5 |
Software - Schedule of Estimate
Software - Schedule of Estimated Amortization Expense of Capitalized Intangible Assets (Details) - USD ($) $ in Thousands | Sep. 30, 2022 | Dec. 31, 2021 |
Finite Lived Intangible Assets [Line Items] | ||
2022 (October - December) | $ 522 | |
2023 | 2,993 | |
2024 | 2,530 | |
2025 | 1,518 | |
2026 | 203 | |
Thereafter | 6 | |
Net balance | 7,772 | $ 5,867 |
Acquired and Internal Use Software | ||
Finite Lived Intangible Assets [Line Items] | ||
2022 (October - December) | 80 | |
2023 | 244 | |
2024 | 130 | |
2025 | 82 | |
2026 | 70 | |
Thereafter | 6 | |
Net balance | 612 | |
Software Marketed for External Use | ||
Finite Lived Intangible Assets [Line Items] | ||
2022 (October - December) | 442 | |
2023 | 2,749 | |
2024 | 2,400 | |
2025 | 1,436 | |
2026 | 133 | |
Thereafter | ||
Net balance | $ 7,160 |
Goodwill and Intangible Asset_2
Goodwill and Intangible Assets - Additional Information (Details) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 USD ($) | Sep. 30, 2021 USD ($) | Sep. 30, 2022 USD ($) Unit Segment Subsidiary | Sep. 30, 2021 USD ($) | |
Goodwill and Intangible Assets Disclosure [Abstract] | ||||
Number of operating segment | Segment | 1 | |||
Number of reportable segments | Segment | 1 | |||
Number of operating subsidiaries | Subsidiary | 2 | |||
Adjustments to carrying value of goodwill | $ 0 | |||
Number of reporting unit | Unit | 1 | |||
Impairment of goodwill | $ 0 | |||
Amortization expense | $ 400,000 | $ 600,000 | $ 1,200,000 | $ 1,700,000 |
Goodwill and Intangible Asset_3
Goodwill and Intangible Assets - Schedule of Carrying Amount and Amortization of Intangible Assets (Details) - USD ($) $ in Thousands | 9 Months Ended | |
Sep. 30, 2022 | Dec. 31, 2021 | |
Finite Lived Intangible Assets [Line Items] | ||
Gross carrying amount | $ 50,530 | $ 50,530 |
Accumulated amortization | (40,982) | (39,753) |
Total amortization | 9,548 | 10,777 |
Unpatented Technology | ||
Finite Lived Intangible Assets [Line Items] | ||
Gross carrying amount | 14,660 | 14,660 |
Accumulated amortization | (14,660) | (14,555) |
Total amortization | $ 0 | 105 |
Unpatented Technology | Minimum | ||
Finite Lived Intangible Assets [Line Items] | ||
Useful Life | 3 years | |
Unpatented Technology | Maximum | ||
Finite Lived Intangible Assets [Line Items] | ||
Useful Life | 7 years | |
Customer Relationships | ||
Finite Lived Intangible Assets [Line Items] | ||
Gross carrying amount | $ 19,300 | 19,300 |
Accumulated amortization | (9,752) | (8,628) |
Total amortization | $ 9,548 | 10,672 |
Customer Relationships | Minimum | ||
Finite Lived Intangible Assets [Line Items] | ||
Useful Life | 5 years | |
Customer Relationships | Maximum | ||
Finite Lived Intangible Assets [Line Items] | ||
Useful Life | 18 years | |
Patents | ||
Finite Lived Intangible Assets [Line Items] | ||
Useful Life | 7 years | |
Gross carrying amount | $ 11,300 | 11,300 |
Accumulated amortization | $ (11,300) | (11,300) |
Trademarks | ||
Finite Lived Intangible Assets [Line Items] | ||
Useful Life | 10 years | |
Gross carrying amount | $ 5,270 | 5,270 |
Accumulated amortization | $ (5,270) | $ (5,270) |
Goodwill and Intangible Asset_4
Goodwill and Intangible Assets - Schedule of Estimated Amortization Expense of Capitalized Intangible Assets (Details) - USD ($) $ in Thousands | Sep. 30, 2022 | Dec. 31, 2021 |
Finite-Lived Intangible Assets, Net [Abstract] | ||
2022 (October - December) | $ 374 | |
2023 | 1,498 | |
2024 | 1,498 | |
2025 | 1,498 | |
2026 | 1,498 | |
Thereafter | 3,182 | |
Total amortization | $ 9,548 | $ 10,777 |
Debt - Additional Information (
Debt - Additional Information (Details) - USD ($) | 3 Months Ended | 9 Months Ended | |||||
Nov. 17, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | Jun. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | Dec. 31, 2021 | |
Debt Instrument [Line Items] | |||||||
Net interest expense | $ 500,000 | $ 700,000 | $ 1,400,000 | $ 3,200,000 | |||
Amortization of debt issuance costs associated with excess cash flow payment | $ 19,600,000 | $ 300,000 | |||||
BofA Credit Agreement | |||||||
Debt Instrument [Line Items] | |||||||
Debt outstanding | 28,688,000 | $ 28,688,000 | |||||
Debt instrument, maturity date | Nov. 17, 2026 | ||||||
Line of credit facility, maximum borrowing capacity | $ 75,000,000 | ||||||
Undrawn commitment fee | 0.20% | ||||||
Debt instrument, principal payments | $ 700,000 | ||||||
Debt instrument, frequency of payment | quarterly | ||||||
BofA Credit Agreement | LIBOR Rate | |||||||
Debt Instrument [Line Items] | |||||||
Debt instrument, interest rate terms | Interest accrues on the outstanding principal amount of the Term and Revolving Facilities on a quarterly basis and is equal to a base rate equal rate per annum determined by reference to the 1-month, 3-month or 6-month US Dollar LIBOR rate as selected by the Company, plus an applicable margin between 1.75% to 2.25% as determined by the Company’s performance as measured by the consolidated leverage ratio. | ||||||
Term Loan Facility | |||||||
Debt Instrument [Line Items] | |||||||
Debt outstanding | 28,688,000 | $ 28,688,000 | $ 30,000,000 | ||||
Term Loan Facility | Eurodollar Rate | |||||||
Debt Instrument [Line Items] | |||||||
Debt outstanding | 30,000,000 | ||||||
Term Loan Facility | Bank of American | |||||||
Debt Instrument [Line Items] | |||||||
Debt outstanding | $ 28,700,000 | $ 28,700,000 | |||||
Term Loan Facility | BofA Credit Agreement | |||||||
Debt Instrument [Line Items] | |||||||
Debt outstanding | $ 30,000,000 | ||||||
Debt instrument, maturity date | Nov. 17, 2026 | ||||||
Debt instrument term | 5 years | ||||||
Debt instrument, effective interest rate | 5.15% | 5.15% | |||||
Term Loan Facility | BofA Credit Agreement | Applicable Margin Rate | |||||||
Debt Instrument [Line Items] | |||||||
Debt instrument base rate | 1.75% | ||||||
Term Loan Facility | BofA Credit Agreement | LIBOR Rate | |||||||
Debt Instrument [Line Items] | |||||||
Debt instrument, interest rate terms | On December 31, 2021, the 1-week and 2-month US Dollar LIBOR ceased, but the remaining five US Dollar LIBOR tenors (overnight and 1-month, 3-month, 6-month and 12-month) will not cease until June 30, 2023 | ||||||
Revolving Credit Facility | |||||||
Debt Instrument [Line Items] | |||||||
Debt outstanding | $ 0 | $ 0 | |||||
Revolving Credit Facility | Silicon Valley Bank | |||||||
Debt Instrument [Line Items] | |||||||
Debt Instrument amount available under credit facility | $ 45,000,000 | $ 45,000,000 | |||||
Revolving Credit Facility | BofA Credit Agreement | |||||||
Debt Instrument [Line Items] | |||||||
Debt instrument, maturity date | Nov. 17, 2026 | ||||||
Line of credit facility, maximum borrowing capacity | $ 45,000,000 | ||||||
Debt instrument term | 5 years | ||||||
Sublimit for Issuance of Letters of Credit | BofA Credit Agreement | |||||||
Debt Instrument [Line Items] | |||||||
Line of credit facility, maximum borrowing capacity | $ 5,000,000 | ||||||
Swingline Loans | BofA Credit Agreement | |||||||
Debt Instrument [Line Items] | |||||||
Line of credit facility, maximum borrowing capacity | $ 5,000,000 | ||||||
Maximum | BofA Credit Agreement | |||||||
Debt Instrument [Line Items] | |||||||
Undrawn commitment fee | 0.25% | ||||||
Maximum | BofA Credit Agreement | Applicable Margin Rate | |||||||
Debt Instrument [Line Items] | |||||||
Debt instrument base rate | 2.25% | ||||||
Minimum | BofA Credit Agreement | |||||||
Debt Instrument [Line Items] | |||||||
Undrawn commitment fee | 0.20% | ||||||
Minimum | BofA Credit Agreement | Applicable Margin Rate | |||||||
Debt Instrument [Line Items] | |||||||
Debt instrument base rate | 1.75% |
Debt - Schedule of Current and
Debt - Schedule of Current and Noncurrent Portions of External Debt Facilities (Details) - USD ($) $ in Thousands | Sep. 30, 2022 | Dec. 31, 2021 |
Debt Instrument [Line Items] | ||
Less debt issuance costs | $ (443) | $ (546) |
Total debt | 28,245 | 29,454 |
Less current portion of term facility | (3,281) | (2,625) |
Current portion of debt issuance costs | 126 | 136 |
Total long-term external debt, net | 25,090 | 26,965 |
Term Loan Facility | ||
Debt Instrument [Line Items] | ||
Long-term debt, Gross | $ 28,688 | $ 30,000 |
Debt - Schedule of Maturities o
Debt - Schedule of Maturities on External Debt Outstanding (Details) - BofA Credit Agreement $ in Thousands | Sep. 30, 2022 USD ($) |
Debt Instrument [Line Items] | |
2022 (October - December) | $ 1,313 |
2023 | 2,625 |
2024 | 2,625 |
2025 | 2,625 |
2026 | 19,500 |
Total | $ 28,688 |
Employee Benefit Plans - Additi
Employee Benefit Plans - Additional Information (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
U.S. Pan | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Defined contribution plan, employer matching contribution, percent of match | 100% | |||
Defined contribution plan, maximum annual contributions per employee, percent | 4% | |||
Defined contribution plan employers matching contribution vesting period | 2 years | |||
Defined contribution plan, employer discretionary contribution amount | $ 0.2 | $ 0.2 | $ 1.2 | $ 1 |
UK Plan | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Defined contribution plan, employer matching contribution, percent of match | 5% | |||
Defined contribution plan, maximum annual contributions per employee, percent | 7% | |||
Defined contribution plan, employer discretionary contribution amount | $ 0.1 | $ 0.1 | $ 0.3 | $ 0.3 |
Defined contribution plan, employee matching contribution, percent of match | 3% | |||
Defined contribution plan, employer matching contribution, percent of employees' gross pay | 1% |
Other expense (income), net - A
Other expense (income), net - Additional Information (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Net Other Expense | ||||
Other Non Operating Income and Expense [Line Items] | ||||
Foreign exchange (gains) and losses | $ 0.2 | $ 0.1 | $ (0.1) | $ 0.2 |
Share-Based Compensation - Addi
Share-Based Compensation - Additional Information (Details) - USD ($) | 1 Months Ended | 3 Months Ended | 6 Months Ended | 9 Months Ended | ||||
Feb. 25, 2022 | Jun. 30, 2019 | Sep. 30, 2022 | Sep. 30, 2021 | Jun. 30, 2022 | Jun. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||||||
Shares granted | 402,546 | |||||||
Share-based compensation income tax benefits | $ 300,000 | $ 600,000 | $ 800,000 | $ 3,000,000 | ||||
Share-based compensation expense | 7,785,000 | 5,584,000 | ||||||
Pre-tax unrecognized compensation expense, net of estimated forfeitures | $ 25,000,000 | |||||||
Forfeiture rate utilized for estimating forfeitures of options and restricted share units granted | 8.20% | |||||||
Share options contractual term | 10 years | |||||||
Aggregate intrinsic value of options exercisable | 9,925,892 | $ 9,925,892 | ||||||
Share options exercised | 44,119 | |||||||
Unrecognized pre-tax share based compensation expense related to unvested share option awards | 13,700,000 | $ 13,700,000 | ||||||
Shares vested | 192,690 | |||||||
Unrecognized pre-tax compensation expense related to unvested restricted share awards and restricted shares units | 11,300,000 | $ 11,300,000 | ||||||
Share options vesting period | 4 years | |||||||
Vesting period of restricted shares | 4 years | |||||||
Employee Share Purchase Plan | ||||||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||||||
Number of outstanding shares added annually | 275,000 | |||||||
Percentage of outstanding shares | 1% | |||||||
Share-based compensation expense | $ 200,000 | $ 200,000 | $ 700,000 | $ 500,000 | ||||
Percentage of purchase price shares on first trading day of offering period and purchase date | 85% | |||||||
Number of additional shares available under ESPP | 267,352 | |||||||
Shares issued under the ESPP | 87,229 | 39,061 | ||||||
2019 Share Incentive Plan | ||||||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||||||
Number of shares authorized | 1,320,000 | 1,320,000 | 1,320,000 | |||||
Shares granted | 402,546 | |||||||
Percentage of outstanding shares | 5% | |||||||
2019 Share Incentive Plan | Maximum | ||||||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||||||
Number of outstanding shares added annually | 1,320,000 | |||||||
2019 Share Incentive Plan | RSUs | ||||||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||||||
Shares granted | 402,546 | |||||||
Shares vested | 192,690 | |||||||
Shares to pay employees' portion of minimum payroll withholding taxes | 43,109 |
Share-Based Compensation - Summ
Share-Based Compensation - Summary of Changes in Number of Shares Available for Grant (Details) - shares | 9 Months Ended | |
Sep. 30, 2022 | Feb. 25, 2022 | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
RSUs granted | (402,546) | |
Options granted | (963,000) | |
Expirations | 8,799 | |
Forfeitures | 85,958 | |
2019 Share Incentive Plan | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Available for grant, beginning balance | 1,853,240 | |
Added to 2019 Share Incentive Plan | 1,320,000 | 1,320,000 |
RSUs granted | (402,546) | |
Options granted | (963,000) | |
Shares withheld in settlement of taxes and/or exercise price | 43,109 | |
Expirations | 8,799 | |
Forfeitures | 115,493 | |
Available for grant, ending balance | 1,975,095 |
Share-Based Compensation - Sche
Share-Based Compensation - Schedule of Total Share Based Compensation Expense (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Total share-based compensation expense | $ 2,848 | $ 2,076 | $ 7,785 | $ 5,584 |
Cost of Revenues | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Total share-based compensation expense | 56 | 39 | 163 | 108 |
Research and Development | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Total share-based compensation expense | 1,241 | 834 | 3,274 | 2,193 |
Sales and Marketing | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Total share-based compensation expense | 696 | 540 | 1,901 | 1,374 |
General and Administrative | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Total share-based compensation expense | $ 855 | $ 663 | $ 2,447 | $ 1,909 |
Share-Based Compensation - Su_2
Share-Based Compensation - Summary of Stock Option Activity (Details) | 9 Months Ended | 12 Months Ended |
Sep. 30, 2022 USD ($) $ / shares shares | Dec. 31, 2021 USD ($) $ / shares shares | |
Options | ||
Options outstanding, Beginning balance | shares | 2,797,992 | |
Options granted | shares | 963,000 | |
Options exercised | shares | (44,119) | |
Options expired | shares | (8,799) | |
Options forfeited | shares | (85,958) | |
Options outstanding, Ending balance | shares | 3,622,116 | 2,797,992 |
Options exercisable | shares | 1,833,090 | |
Options vested and expected to vest | shares | 3,547,231 | |
Weighted average exercise price | ||
Weighted average exercise price, Outstanding beginning balance | $ / shares | $ 12.64 | |
Weighted average exercise price, Options granted | $ / shares | 15.61 | |
Weighted average exercise price, Options exercised | $ / shares | 8.20 | |
Weighted average exercise price, Options expired | $ / shares | 14.77 | |
Weighted average exercise price, Options forfeited | $ / shares | 8.53 | |
Weighted average exercise price, Outstanding ending balance | $ / shares | 13.58 | $ 12.64 |
Weighted average exercise price, Options exercisable | $ / shares | 12.10 | |
Weighted average exercise price, Options vested and expected to vest | $ / shares | $ 13.56 | |
Weighted average remaining contractual term (years) | ||
Weighted average remaining contractual term, Options outstanding | 7 years 7 months 6 days | 7 years 10 months 24 days |
Weighted average remaining contractual term, Options exercisable | 6 years 6 months | |
Weighted average remaining contractual term, Options vested and expected to vest | 7 years 6 months | |
Aggregate intrinsic value, Outstanding | $ | $ 15,206,759 | $ 38,295,799 |
Aggregate intrinsic value, Options exercisable | $ | 9,925,892 | |
Aggregate intrinsic value, Options vested and expected to vest | $ | $ 14,940,070 |
Share-Based Compensation - Sc_2
Share-Based Compensation - Schedule of Estimated Fair Value of Weighted Average Assumptions (Details) - $ / shares | 9 Months Ended | |
Sep. 30, 2022 | Sep. 30, 2021 | |
Share-Based Payment Arrangement [Abstract] | ||
Risk-free interest rate | 2.96% | 1.14% |
Weighted-average expected volatility | 72.90% | 50.90% |
Expected term (in years) | 5 years 6 months | 6 years 6 months |
Weighted average grant-date fair value per share of options granted | $ 9.94 | $ 21.36 |
Share-Based Compensation - Su_3
Share-Based Compensation - Summary of Restricted Shares Activity (Details) | 9 Months Ended |
Sep. 30, 2022 $ / shares shares | |
Number of Units | |
Number of Units, RSUs, beginning balance | shares | 547,343 |
Number of Units, RSUs granted | shares | 402,546 |
Number of Units, RSUs vested | shares | (192,690) |
Number of Units, RSUs forfeited | shares | (29,535) |
Number of Units, RSUs, ending balance | shares | 727,664 |
Weighted average grant date fair value | |
Weighted average grant date fair value, RSUs, beginning balance | $ / shares | $ 22.47 |
Weighted average grant date fair value, RSUs granted | $ / shares | 15.14 |
Weighted average grant date fair value, RSUs vested | $ / shares | 22.99 |
Weighted average grant date fair value, RSUs forfeited | $ / shares | 23.70 |
Weighted average grant date fair value, RSUs, ending balance | $ / shares | $ 18.23 |
Share Capital - Shares (Share C
Share Capital - Shares (Share Capital Activity) (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | 9 Months Ended | |||
Sep. 30, 2022 | Sep. 30, 2021 | Jun. 30, 2022 | Jun. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Schedule Of Capitalization Equity [Line Items] | ||||||
Share options exercised, shares | 44,119 | |||||
Share options exercised | $ 113 | $ 1,196 | $ 362 | $ 4,541 | ||
Share Capital | ||||||
Schedule Of Capitalization Equity [Line Items] | ||||||
Beginning balance, shares | 26,964,000 | 26,503,000 | 26,735,175 | 26,035,000 | 26,735,175 | 26,035,000 |
Issuance of ordinary shares under employee share purchase plan, shares | 87,229 | 39,000 | ||||
Issuance of vested shares, Number of shares | 47,000 | 34,000 | 192,690 | 195,000 | ||
Share options exercised, shares | 17,000 | 113,000 | 44,119 | 425,000 | ||
Shares withheld for net settlement of shares issued, Number of shares | (12,000) | (11,000) | (43,109) | (55,000) | ||
Ending balance, shares | 27,016,104 | 26,639,000 | 26,964,000 | 26,503,000 | 27,016,104 | 26,639,000 |
Beginning balance | $ 3 | $ 3 | ||||
Ending balance | $ 3 | $ 3 |
Share Capital - Shares - Additi
Share Capital - Shares - Additional Information (Details) | 9 Months Ended |
Sep. 30, 2022 $ / shares | |
Stockholders' Equity Note [Abstract] | |
Common stock dividends declared | $ 0 |
Common stock dividends paid | $ 0 |
Earnings Per Share - Computatio
Earnings Per Share - Computation of Basic and Diluted Net Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Numerator: | ||||
Net income | $ 9,435 | $ 4,617 | $ 10,189 | $ 35,994 |
Denominator: | ||||
Basic weighted average shares outstanding | 26,977,155 | 26,540,843 | 26,855,395 | 26,342,113 |
Dilutive effect of share option awards | 755,196 | 1,785,873 | 840,828 | 1,968,804 |
Dilutive effect of restricted share units and restricted share awards | 242,443 | 312,459 | 235,509 | 382,951 |
Dilutive effect of employee share purchase plan | 4,781 | 2 | 7,996 | 11,809 |
Diluted weighted average shares outstanding | 27,979,575 | 28,639,177 | 27,939,728 | 28,705,677 |
Net earnings per share, basic | $ 0.35 | $ 0.17 | $ 0.38 | $ 1.37 |
Net earnings per share, diluted | $ 0.34 | $ 0.16 | $ 0.36 | $ 1.25 |
Income Taxes - Additional Infor
Income Taxes - Additional Information (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | Dec. 31, 2021 | |
Schedule Of Income Taxes [Line Items] | |||||
Provision (benefit) for income taxes | $ (154) | $ 355 | $ (1,048) | $ (5,899) | |
Effective tax rate | (1.70%) | 7.10% | (11.50%) | (19.60%) | |
Statutory rate | 21% | 21% | 21% | 21% | |
Non-recurring tax benefit related to valuation allowance reversal | $ 7,700 |
Segment Information - Additiona
Segment Information - Additional Information (Details) | 9 Months Ended |
Sep. 30, 2022 Segment | |
Segment Reporting [Abstract] | |
Number of reporting segments | 1 |
Number of operating segment | 1 |
Revenues from Contracts with _3
Revenues from Contracts with Customers - Schedule of Revenue by Product Category (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Disaggregation Of Revenue [Line Items] | ||||
Revenues | $ 81,200 | $ 75,920 | $ 212,392 | $ 257,144 |
Sales Revenue, Product Line | Product Concentration Risk | ||||
Disaggregation Of Revenue [Line Items] | ||||
Concentration risk, percentage | 100% | 100% | 100% | 100% |
Point-to-Multi-Point | ||||
Disaggregation Of Revenue [Line Items] | ||||
Revenues | $ 26,090 | $ 50,144 | $ 85,285 | $ 167,739 |
Point-to-Multi-Point | Sales Revenue, Product Line | Product Concentration Risk | ||||
Disaggregation Of Revenue [Line Items] | ||||
Concentration risk, percentage | 32% | 66% | 40% | 65% |
Point-to-Point | ||||
Disaggregation Of Revenue [Line Items] | ||||
Revenues | $ 15,409 | $ 13,890 | $ 45,807 | $ 45,432 |
Point-to-Point | Sales Revenue, Product Line | Product Concentration Risk | ||||
Disaggregation Of Revenue [Line Items] | ||||
Concentration risk, percentage | 19% | 18% | 21% | 18% |
Enterprise | ||||
Disaggregation Of Revenue [Line Items] | ||||
Revenues | $ 38,330 | $ 10,734 | $ 77,852 | $ 41,154 |
Enterprise | Sales Revenue, Product Line | Product Concentration Risk | ||||
Disaggregation Of Revenue [Line Items] | ||||
Concentration risk, percentage | 47% | 14% | 37% | 16% |
Other | ||||
Disaggregation Of Revenue [Line Items] | ||||
Revenues | $ 1,371 | $ 1,152 | $ 3,448 | $ 2,819 |
Other | Sales Revenue, Product Line | Product Concentration Risk | ||||
Disaggregation Of Revenue [Line Items] | ||||
Concentration risk, percentage | 2% | 2% | 2% | 1% |
Revenues from Contracts with _4
Revenues from Contracts with Customers - Schedule of Revenue by Geography (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Disaggregation Of Revenue [Line Items] | ||||
Revenues | $ 81,200 | $ 75,920 | $ 212,392 | $ 257,144 |
Sales Revenue, Product Line | Geographic Concentration Risk | ||||
Disaggregation Of Revenue [Line Items] | ||||
Concentration risk, percentage | 100% | 100% | 100% | 100% |
North America | ||||
Disaggregation Of Revenue [Line Items] | ||||
Revenues | $ 30,086 | $ 36,564 | $ 89,547 | $ 140,105 |
North America | Sales Revenue, Product Line | Geographic Concentration Risk | ||||
Disaggregation Of Revenue [Line Items] | ||||
Concentration risk, percentage | 37% | 48% | 42% | 54% |
Europe, Middle East and Africa | ||||
Disaggregation Of Revenue [Line Items] | ||||
Revenues | $ 29,263 | $ 23,414 | $ 70,876 | $ 67,047 |
Europe, Middle East and Africa | Sales Revenue, Product Line | Geographic Concentration Risk | ||||
Disaggregation Of Revenue [Line Items] | ||||
Concentration risk, percentage | 36% | 31% | 34% | 26% |
Caribbean and Latin America | ||||
Disaggregation Of Revenue [Line Items] | ||||
Revenues | $ 8,935 | $ 7,993 | $ 21,979 | $ 30,660 |
Caribbean and Latin America | Sales Revenue, Product Line | Geographic Concentration Risk | ||||
Disaggregation Of Revenue [Line Items] | ||||
Concentration risk, percentage | 11% | 11% | 10% | 12% |
Asia Pacific | ||||
Disaggregation Of Revenue [Line Items] | ||||
Revenues | $ 12,916 | $ 7,949 | $ 29,990 | $ 19,332 |
Asia Pacific | Sales Revenue, Product Line | Geographic Concentration Risk | ||||
Disaggregation Of Revenue [Line Items] | ||||
Concentration risk, percentage | 16% | 10% | 14% | 8% |
Revenues from Contracts with _5
Revenues from Contracts with Customers - Summary of Contract Balances (Details) - USD ($) $ in Thousands | Sep. 30, 2022 | Dec. 31, 2021 |
Revenue from Contract with Customer [Abstract] | ||
Trade accounts receivable, net of allowance for credit losses | $ 83,679 | $ 68,788 |
Deferred revenue - current | 8,226 | 6,880 |
Deferred revenue - noncurrent | 8,201 | 5,363 |
Refund liability | $ 3,051 | $ 2,516 |
Revenues from Contracts with _6
Revenues from Contracts with Customers - Additional Information (Details) $ in Millions | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||
Sep. 30, 2022 USD ($) | Sep. 30, 2021 USD ($) | Sep. 30, 2022 USD ($) Customer | Sep. 30, 2021 USD ($) | Dec. 31, 2021 USD ($) Customer | |
Revenue From Contract With Customer [Line Items] | |||||
Deferred revenue | $ 16.4 | $ 16.4 | $ 12.2 | ||
Revenue recognized | $ 1.5 | $ 1.8 | $ 5.7 | $ 5.4 | |
Revenue practical expedient, incremental cost of obtaining contract [true/false] | true | ||||
Minimum | |||||
Revenue From Contract With Customer [Line Items] | |||||
Collection period for trade accounts receivable | 30 days | ||||
Maximum | |||||
Revenue From Contract With Customer [Line Items] | |||||
Collection period for trade accounts receivable | 60 days | ||||
Customer Concentration Risk | Accounts Receivables | |||||
Revenue From Contract With Customer [Line Items] | |||||
Number of customers | Customer | 1 | 1 | |||
Customer Concentration Risk | Accounts Receivables | Customer A | |||||
Revenue From Contract With Customer [Line Items] | |||||
Concentration risk, percentage | 10% | 10% |
Revenues from Contracts with _7
Revenues from Contracts with Customers - Additional Information (Details 1) - USD ($) $ in Millions | Sep. 30, 2022 | Dec. 31, 2021 |
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items] | ||
Deferred revenue | $ 16.4 | $ 12.2 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2022-01-01 | ||
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items] | ||
Remaining performance obligation expected to be recognized period | 1 year | |
Deferred revenue | $ 6.9 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2022-10-01 | ||
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items] | ||
Remaining performance obligation expected to be recognized period | 1 year | |
Deferred revenue | $ 8.2 |
Leases - Components of Lease Ex
Leases - Components of Lease Expense (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Leases [Abstract] | ||||
Operating lease cost | $ 580 | $ 630 | $ 1,781 | $ 1,981 |
Short-term lease cost | 99 | 82 | 352 | 222 |
Variable lease costs | 171 | 125 | 461 | 354 |
Total lease expense | $ 850 | $ 837 | $ 2,594 | $ 2,557 |
Leases - Supplemental Balance S
Leases - Supplemental Balance Sheet Information related to Leases (Details) - USD ($) $ in Thousands | Sep. 30, 2022 | Dec. 31, 2021 |
Operating leases: | ||
Operating lease assets | $ 4,548 | $ 5,899 |
Current lease liabilities | $ 2,001 | $ 2,116 |
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] | Other current liabilities | Other current liabilities |
Noncurrent operating lease liabilities | $ 2,558 | $ 4,112 |
Weighted average remaining lease term (years): | ||
Operating leases | 2 years 9 months 10 days | 3 years 4 months 6 days |
Weighted average discount rate: | ||
Operating leases | 6.12% | 6.15% |
Leases - Supplemental Cash Flow
Leases - Supplemental Cash Flow Information related to Leases (Details) - USD ($) $ in Thousands | 9 Months Ended | |
Sep. 30, 2022 | Sep. 30, 2021 | |
Supplemental cash flow information: | ||
Cash paid for amounts included in the measurement of lease liabilities | $ 1,783 | $ 1,976 |
Leases - Additional Information
Leases - Additional Information (Details) | 9 Months Ended |
Sep. 30, 2022 | |
Leases [Line Items] | |
Lessee operating lease option to extend | true |
Lessee not yet commenced, description | As of September 30, 2022, the Company does not have any leases that have not yet commenced. |
Minimum | |
Leases [Line Items] | |
Lessee operating lease term of contract | 1 year |
Lessee operating lease option to extend period | 1 year |
Maximum | |
Leases [Line Items] | |
Lessee operating lease term of contract | 4 years |
Lessee operating lease option to extend period | 4 years |
Leases - Remaining Maturities o
Leases - Remaining Maturities on Lease Liabilities (Details) $ in Thousands | Sep. 30, 2022 USD ($) |
Leases [Abstract] | |
2022 (October - December) | $ 611 |
2023 | 2,093 |
2024 | 1,086 |
2025 | 783 |
2026 | 374 |
Total lease payments | 4,947 |
Less: interest | 388 |
Present value of lease liabilities | $ 4,559 |
Related Party Transactions - Ad
Related Party Transactions - Additional Information (Details) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Vector Capital Management L.P. | ||||
Related Party Transaction [Line Items] | ||||
Related party transactions | $ 0 | $ 0 | $ 0 | $ 0 |